Source of data: companies
| NLEM Unique No. | Composition as per NLEM | PACK_DESC | BRANDS | Company | Strength | Pack size | Unit | MAT Sep’14 Value | MAT% | PTR Sep’14 | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.5.3.1.2.2 | Chloroquine phosphate Injection 40 mg / ml (64.5mg = 40mg chloroquine) | NIVAQUINE P 40 MG INJECTION 5 ML | Nivaquine | ABBOTT HEALTHCARE PVT. LT | 40 | 5 | ML | 0.76 | 5.98% | 5.21 | 1.04 | -- |
-- |
Chloroquine phosphate Injection 40 mg / ml (64.5mg = 40mg chloroquine) | NIVAQUINE P 40 MG INJECTION 2 ML | Nivaquine | ABBOTT HEALTHCARE PVT. LT | 40 | 2 | ML | 0.55 | 4.32% | 3.32 | 1.66 | -- |
-- |
Chloroquine phosphate Injection 40 mg / ml (64.5mg = 40mg chloroquine) | NIVAQUINE P 40 MG INJECTION 30 ML | Nivaquine | ABBOTT HEALTHCARE PVT. L | 40 | 30 | ML | 0.21 | 1.63% | 15.86 | 0.53 | -- |
-- |
Chloroquine phosphate Injection 40 mg / ml (64.5mg = 40mg chloroquine) | LARIAGO 40 MG INJECTION 30 ML | -- |
IPCA LABORATORIES PVT LTD. | 40 | 30 | ML | 8.06 | 63.58% | 17.01 | 0.57 | -- |
-- |
Chloroquine phosphate Injection 40 mg / ml (64.5mg = 40mg chloroquine) | LARIAGO 40 MG INJECTION 5 ML | -- |
IPCA LABORATORIES PVT LTD. | 40 | 5 | ML | 1.88 | 14.83% | 5.58 | 1.12 | -- |
-- |
Chloroquine phosphate Injection 40 mg / ml (64.5mg = 40mg chloroquine) | LARIAGO 40 MG INJECTION 2 ML | -- |
IPCA LABORATORIES PVT LT | 40 | 2 | ML | 0.51 | 4.02% | 3.55 | 1.78 | -- |
-- |
Chloroquine phosphate Injection 40 mg / ml (64.5mg = 40mg chloroquine) | EMQUIN 40 MG INJECTION 30 ML | -- |
MERCK LTD | 40 | 30 | ML | 0.71 | 5.64% | 15.52 | 0.52 | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
12.7 | 100.00% | -- |
1.03 | 1.19 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
maximum | 1.78 | minimum | 0.52 |
-- |
As per the above there are 3 companies consisting of Market Share of 1% & Abo | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Sum of MAT value considered for price calculation | 1,268.00 | (Rs. in lakh) | -- |
-- |
-- |
-- |
-- |
-- |
-- |
||
-- |
Sum of PTR per unit considered for price calculation | 7.22 | -- |
-- |
-- |
-- |
||||||
-- |
Number of Packs considered | 7 | -- |
-- |
||||||||
-- |
Average PTR | 1.03 | -- |
-- |
||||||||
-- |
Add : 16% Retailer Margin | 0.16 | -- |
-- |
||||||||
-- |
Ceiling Price (without local taxes) | 1.19 | -- |
-- |
||||||||
-- |
% Reduction with compared to Highest Price | 42.13% | -- |
-- |
||||||||
-- |
-- |
-- |
-- |
-- |
||||||||
-- |
WPI increase on 1 April, 2015 | 3.849% | -- |
|||||||||
-- |
Ceiling Price after WPI Adjustment (Effective from 01.04.2015) | 1.24 | S.O. No. 834(E) dt. 25.03.2015 | -- |
-- |
-- |
||||||
| Source of data: Pharma Trac and companies | ||||||||||||
| 6.5.3.1.2.3 | Chloroquine phosphate Syrup 50 mg / 5ml | NIVAQUINE P 50 MG SUSPENSION 60 | NIVAQUINE | ABBOTT HEALTHCARE PVT. L | 50 | 60 | ML | 2.03 | 13.69% | 14.22 | 0.24 | -- |
-- |
Chloroquine phosphate Syrup 50 mg / 5ml | BITAQUINE 50 MG SUSPENSION 60 ML | -- |
BOMBAY TABLET MFG.CO.PVT. | 50 | 60 | ML | 0.08 | 0.51% | 12.18 | 0.20 | -- |
-- |
Chloroquine phosphate Syrup 50 mg / 5ml | LARIAGO 50 MG SUSPENSION 60 ML | -- |
IPCA LABORATORIES PVT LT | 50 | 60 | ML | 10.17 | 68.41% | 15.28 | 0.25 | -- |
-- |
Chloroquine phosphate Syrup 50 mg / 5ml | MATCH-Q 50 MG SUSPENSION 60 ML | -- |
MANKIND PHARMACEUTICAL | 50 | 60 | ML | 0.38 | 2.56% | 12.18 | 0.20 | -- |
-- |
Chloroquine phosphate Syrup 50 mg / 5ml | Emquin Susp 80 mg 60 ml x (/5ml) equivalent to 50 mg of chloroquine base | -- |
Merck Limited | 50 | 60 | ML | 2.02 | 13.56% | 12.18 | 0.20 | -- |
-- |
Chloroquine phosphate Syrup 50 mg / 5ml | PARAQUIN 50 MG SUSPENSION 60 ML | -- |
SHREYA LIFE SCIENCES PVT. | 50 | 60 | ML | 0.09 | 0.60% | 13.16 | 0.22 | -- |
-- |
Chloroquine phosphate Syrup 50 mg / 5ml | TROYQUIN Suspension 60 ML | -- |
Troikaa Pharmaceuticals Ltd | 50 | 60 | ML | 0.10 | 0.67% | 13.22 | 0.22 | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
14.87 | 100.00% | -- |
0.22 | 0.26 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
maximum | 0.25 | minimum | 0.20 |
-- |
As per the above there are 4 companies consisting of Market Share of 1% & Abo | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Sum of MAT value considered for price calculation | 1,460.00 | (Rs. in lakh) | -- |
-- |
-- |
-- |
-- |
-- |
-- |
||
-- |
Sum of PTR per unit considered for price calculation | 0.89 | -- |
-- |
-- |
-- |
||||||
-- |
Number of Packs considered | 4 | -- |
-- |
||||||||
-- |
Average PTR | 0.22 | -- |
-- |
||||||||
-- |
Add : 16% Retailer Margin | 0.04 | -- |
-- |
||||||||
-- |
Ceiling Price (without local taxes) | 0.26 | -- |
-- |
||||||||
-- |
% Reduction with compared to Highest Price | 12.00% | -- |
-- |
||||||||
-- |
-- |
-- |
-- |
-- |
||||||||
-- |
WPI increase on 1 April, 2015 | 3.849% | -- |
|||||||||
-- |
Ceiling Price after WPI Adjustment (Effective from 01.04.2015) | 0.27 | S.O. No. 834(E) dt. 25.03.2015 | -- |
-- |
-- |
||||||
| Source of data: Companies | ||||||||||||
| 6.2.2.6.1 | Erythromycin Estolate Syrup 125 mg/5 ml | Eltocin suspension 60 ml | -- |
IPCA LABORATORIES PVT LT | 125/5ml | 60 | Ml | 2.29 | 13.57% | 24.60 | 0.41 | -- |
-- |
Erythromycin Estolate Syrup 125 mg/5 ml | Althrocin Liquid 60 ml | -- |
Alembic | 125/5ml | 60 | ML | 14.56 | 86.27% | 24.60 | 0.41 | -- |
-- |
Erythromycin Estolate Syrup 125 mg/5 ml | E-mycin suspension | -- |
Themis pharmaceuticals | 125/5ml | 100 | ML | 0.03 | 0.16% | 35.37 | 0.35 | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
16.9 | 100.00% | -- |
0.41 | 0.48 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
maximum | 0.41 | minimum | 0.41 |
-- |
As per the above there are 2 companies consisting of Market Share of 1% & Abo | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Sum of MAT value considered for price calculation | 1,685.00 | (Rs. in lakh) | -- |
-- |
-- |
-- |
-- |
-- |
-- |
||
-- |
Sum of PTR per unit considered for price calculation | 0.82 | -- |
-- |
-- |
-- |
||||||
-- |
Number of Packs considered | 2 | -- |
-- |
||||||||
-- |
Average PTR | 0.41 | -- |
-- |
||||||||
-- |
Add : 16% Retailer Margin | 0.07 | -- |
-- |
||||||||
-- |
Ceiling Price (without local taxes) | 0.48 | -- |
-- |
||||||||
-- |
% Reduction with compared to Highest Price | 0.00% | -- |
-- |
||||||||
-- |
-- |
-- |
-- |
-- |
||||||||
-- |
WPI increase on 1 April, 2015 | 3.849% | -- |
|||||||||
-- |
Ceiling Price after WPI Adjustment (Effective from 01.04.2015) | 0.50 | S.O. No. 834(E) dt. 25.03.2015 | -- |
||||||||
| Source of data: Companies | ||||||||||||
| 6.2.2.6.2.1 | Erythromycin Estolate Tablets 250 mg | Eltocin 250 mg Tablet 10’s | -- |
IPCA LABORATORIES PVT LT | 250 | 10 | Tablet | 2.99 | 8.85% | 23.70 | 2.37 | -- |
-- |
Erythromycin Estolate Tablets 250 mg | Althrocin 250 tablets 10 | -- |
Alembic | 250 | 10 | Tablet | 30.76 | 91.06% | 23.70 | 2.37 | -- |
-- |
Erythromycin Estolate Tablets 250 mg | E-Mycin 250 tablets 10T | -- |
Themis Pharmaceuticals | 250 | 10 | Tablet | 0.03 | 0.09% | 19.73 | 1.97 | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
33.78 | 100.00% | -- |
2.37 | 2.75 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
maximum | 2.37 | minimum | 2.37 |
-- |
As per the above there are 2 companies consisting of Market Share of 1% & Abo | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Sum of MAT value considered for price calculation | 3,375.00 | (Rs. in lakh) | -- |
-- |
-- |
-- |
-- |
-- |
-- |
||
-- |
Sum of PTR per unit considered for price calculation | 4.74 | -- |
-- |
-- |
-- |
||||||
-- |
Number of Packs considered | 2 | -- |
-- |
||||||||
-- |
Average PTR | 2.37 | -- |
-- |
||||||||
-- |
Add : 16% Retailer Margin | 0.38 | -- |
-- |
||||||||
-- |
Ceiling Price (without local taxes) | 2.75 | -- |
-- |
||||||||
-- |
% Reduction with compared to Highest Price | 0.00% | -- |
-- |
||||||||
-- |
-- |
-- |
-- |
-- |
||||||||
-- |
WPI increase on 1 April, 2015 | 3.849% | -- |
|||||||||
-- |
Ceiling Price after WPI Adjustment (Effective from 01.04.2015) | 2.86 | S.O. No. 834(E) dt. 25.03.2015 | -- |
-- |
-- |
||||||
-- |
||||||||||||
| Source of data: Companies | ||||||||||||
| 6.2.2.6.2.2 | Erythromycin Estolate Tablets 500 mg | ALTHROCIN 500 MG TABLET 10 | -- |
ALEMBIC LTD | 500 | 10 | Tablet | 29.30 | 90.57% | 46.10 | 4.61 | -- |
-- |
Erythromycin Estolate Tablets 500 mg | ELTOCIN DS 500 MG TABLET 10 | -- |
IPCA LABORATORIES PVT LT | 500 | 10 | Tablet | 3.05 | 9.43% | 46.10 | 4.61 | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
32.35 | 100.00% | -- |
4.61 | 5.35 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
maximum | 4.61 | minimum | 4.61 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
As per the above there are 2 companies consisting of Market Share of 1% & Abo | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Sum of MAT value considered for price calculation | 3,235.00 | (Rs. in lakh) | -- |
-- |
-- |
-- |
-- |
-- |
-- |
||
-- |
Sum of PTR per unit considered for price calculation | 9.22 | -- |
-- |
-- |
-- |
||||||
-- |
Number of Packs considered | 2 | -- |
-- |
-- |
-- |
-- |
|||||
-- |
Average PTR | 4.61 | -- |
-- |
||||||||
-- |
Add : 16% Retailer Margin | 0.74 | -- |
-- |
||||||||
-- |
Ceiling Price (without local taxes) | 5.35 | -- |
-- |
||||||||
-- |
% Reduction with compared to Highest Price | 0.00% | -- |
-- |
||||||||
-- |
-- |
-- |
-- |
-- |
||||||||
-- |
WPI increase on 1 April, 2015 | 3.849% | -- |
|||||||||
-- |
Ceiling Price after WPI Adjustment (Effective from 01.04.2015) | 5.56 | S.O. No. 834(E) dt. 25.03.2015 | -- |
||||||||
-- |
||||||||||||
| Source of data: Pharma Trac and companies | ||||||||||||
| 18.5.1.2, | Intermediate Acting(Lente/NPH Insulin) | Isophane insulin injection IP (NPH) 40 IU | -- |
BIOCON LTD | 40 | 10 | ML | 0.5 | 0.10% | 113.52 | 11.35 | -- |
| 18.5.1.3 & | Insulin Injection (Soluble) Injection 40 IU / ml | Insulin Injection IP, Soluble insulin (Reg) 40I | -- |
BIOCON LTD | 40 | 10 | ML | 0.9 | 0.20% | 113.52 | 11.35 | -- |
| 18.5.1.5 | Premix Insulin 30:70 injection Injection 40IU/ml | Biphasic isophane insuling injection IP (30/7 | -- |
BIOCON LTD | 40 | 10 | ML | 5.0 | 1.09% | 113.52 | 11.35 | -- |
-- |
Insulin Injection (Soluble) Injection 40 IU / ml | HUMARAP 40 IU VIAL 10 ML | -- |
CADILA PHARMACEUTICALS LT | 40 | 10 | ML | 0.3 | 0.06% | 113.5 | 11.35 | -- |
-- |
Premix Insulin 30:70 injection Injection 40IU/ml | HUMSTARD 30/70 40IU VIAL 10 ML | -- |
CADILA PHARMACEUTICALS LT | 40 | 10 | ML | 2.3 | 0.51% | 113.5 | 11.35 | -- |
-- |
Insulin Injection (Soluble) Injection 40 IU / ml | HUMINSULIN R 40 IU VIAL 10 ML | -- |
ELI LILLY AND COMPANY (IND | 40 | 10 | ML | 11.2 | 2.44% | 112.4 | 11.24 | -- |
-- |
Premix Insulin 30:70 injection Injection 40IU/ml | HUMINSULIN 30/70 40IU VIAL 10 ML | -- |
ELI LILLY AND COMPANY (INDIA | 40 | 10 | ML | 40.9 | 8.95% | 112.4 | 11.24 | -- |
-- |
Insulin Injection (Soluble) Injection 40 IU / ml | Insulin Injection (Soluble) Injection 40 IU / ml | -- |
Gland Pharma Limited | 40 | 10 | ML | 11.6 | 2.55% | 111.71 | 11.17 | -- |
-- |
Intermediate Acting(Lente/NPH Insulin) | Intermediate Acting(Lente/NPH Insulin) | -- |
Gland Pharma Limited | 40 | 10 | ML | 6.8 | 1.49% | 111.71 | 11.17 | -- |
-- |
Premix Insulin 30:70 injection Injection 40IU/ml | Premix Insulin 30:70 injection Injection 40IU/ | -- |
Gland Pharma Limited | 40 | 10 | ML | 45.9 | 10.03% | 111.71 | 11.17 | -- |
-- |
Insulin Injection (Soluble) Injection 40 IU / ml | LUPISULIN-N 40 IU VIAL 10 ML | -- |
LUPIN LTD | 40 | 10 | ML | 1.4 | 0.31% | 123.56 | 12.36 | -- |
-- |
Insulin Injection (Soluble) Injection 40 IU / ml | LUPISULIN-R 40 IU VIAL 10 ML | -- |
LUPIN LTD | 40 | 10 | ML | 4.1 | 0.89% | 123.56 | 12.36 | -- |
-- |
Premix Insulin 30:70 injection Injection 40IU/ml | LUPISULIN-M 30/70 40IU VIAL 10 ML | -- |
LUPIN LTD | 40 | 10 | ML | 18.8 | 4.12% | 123.56 | 12.36 | -- |
-- |
Insulin Injection (Soluble) Injection 40 IU / ml | Insulin Injection (Soluble) Injection 40 IU / ml | -- |
NOVO NORDISK INDIA PVT LT | 40 | 10 | ML | 49.9 | 10.91% | 120.67 | 12.07 | -- |
-- |
Intermediate Acting(Lente/NPH Insulin) | Intermediate Acting(Lente/NPH Insulin) | -- |
NOVO NORDISK INDIA PVT LTD | 40 | 10 | ML | 12.7 | 2.77% | 120.67 | 12.07 | -- |
-- |
Premix Insulin 30:70 injection Injection 40IU/ml | Premix Insulin 30:70 injection Injection 40IU/ | -- |
NOVO NORDISK INDIA PVT LTD | 40 | 10 | ML | 205.8 | 45.01% | 120.67 | 12.07 | -- |
-- |
Insulin Injection (Soluble) Injection 40 IU / ml | INSUCARE R 40 IU VIAL 10 ML | -- |
RANBAXY LABORATORIES LT | 40 | 10 | ML | 1.6 | 0.34% | 113.5 | 11.35 | -- |
-- |
Intermediate Acting(Lente/NPH Insulin) | INSUCARE N 40 IU VIAL 10 ML | -- |
RANBAXY LABORATORIES LTD | 40 | 10 | ML | 0.9 | 0.20% | 113.5 | 11.35 | -- |
-- |
Premix Insulin 30:70 injection Injection 40IU/ml | INSUCARE M 30/70 40IU VIAL 10 ML | -- |
RANBAXY LABORATORIES LTD | 40 | 10 | ML | 6.6 | 1.43% | 119.52 | 11.95 | -- |
-- |
Intermediate Acting(Lente/NPH Insulin) | Insuman Basal 10 ml vial | -- |
SANOFI INDIA LTD. | 40 | 10 | ML | 1.5 | 0.33% | 133.33 | 13.33 | -- |
-- |
Insulin Injection (Soluble) Injection 40 IU / ml | INSUMAN RAPID 40 IU VIAL 10 ML | -- |
SANOFI INDIA LTD. | 40 | 10 | ML | 2.3 | 0.50% | 133.33 | 13.33 | -- |
-- |
Insulin Injection (Soluble) Injection 40 IU / ml | RECOSULIN R 40 IU VIAL 10 ML | -- |
SHREYA LIFE SCIENCES PVT. | 40 | 10 | ML | 0.7 | 0.15% | 120.66 | 12.07 | -- |
-- |
Premix Insulin 30:70 injection Injection 40IU/ml | RECOSULIN M 30/70 40IU VIAL 10 ML | -- |
SHREYA LIFE SCIENCES PVT. | 40 | 10 | ML | 3.9 | 0.85% | 120.66 | 12.07 | -- |
-- |
Insulin Injection (Soluble) Injection 40 IU / ml | HUMAN FASTACT 40 IU VIAL 10 ML | -- |
USV LTD | 40 | 10 | ML | 0.3 | 0.06% | 116.47 | 11.65 | -- |
-- |
Premix Insulin 30:70 injection Injection 40IU/ml | HUMAN MIXACT 30/70 40IU VIAL 10 ML | -- |
USV LTD | 40 | 10 | ML | 5.3 | 1.17% | 123.81 | 12.38 | -- |
-- |
Premix Insulin 30:70 injection Injection 40IU/ml | HUMAN MIXACT H 30/70 40IU VIAL 10 ML | -- |
USV LTD | 40 | 10 | ML | 0.1 | 0.02% | 123.81 | 12.38 | -- |
-- |
Insulin Injection (Soluble) Injection 40 IU / ml | WOSULIN R 40 IU VIAL 10 ML | -- |
WOCKHARDT LTD | 40 | 10 | ML | 3.0 | 0.65% | 115.66 | 11.57 | -- |
-- |
Insulin Injection (Soluble) Injection 40 IU / ml | WOSULIN N 40 IU VIAL 10 ML | -- |
WOCKHARDT LTD | 40 | 10 | ML | 1.4 | 0.30% | 115.37 | 11.54 | -- |
-- |
Premix Insulin 30:70 injection Injection 40IU/ml | WOSULIN 30:70, 40 IU VIAL 10 ML | -- |
WOCKHARDT LTD | 40 | 10 | ML | 11.7 | 2.57% | 115.49 | 11.55 | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
457.30 | 100.00% | -- |
11.73 | 13.61 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
maximum | 12.38 | minimum | 11.17 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
As per the above there are 9 companies consisting of Market Share of 1% & Abo | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Sum of MAT value considered for price calculation | 45,089.00 | (Rs. in lakh) | -- |
-- |
-- |
-- |
-- |
-- |
-- |
||
-- |
Sum of PTR per unit considered for price calculation | 293.19 | -- |
-- |
-- |
-- |
||||||
-- |
Number of Packs considered | 25 | -- |
-- |
||||||||
-- |
Average PTR | 11.73 | -- |
-- |
||||||||
-- |
Add : 16% Retailer Margin | 1.88 | -- |
-- |
||||||||
-- |
Ceiling Price (without local taxes) | 13.61 | -- |
-- |
||||||||
-- |
% Reduction with compared to Highest Price | 5.25% | -- |
-- |
||||||||
-- |
-- |
-- |
-- |
-- |
||||||||
-- |
WPI increase on 1 April, 2015 | 3.849% | -- |
|||||||||
-- |
Ceiling Price after WPI Adjustment (Effective from 01.04.2015) | 14.13 | S.O. No. 834(E) dt. 25.03.2015 | -- |
||||||||
-- |
||||||||||||
| Source of data: Pharma Trac and company | ||||||||||||
| 6.2.2.8.1.1 | Metronidazole Tablet 200mg | FLAGYL 200 MG TABLET 15 | -- |
ABBOTT HEALTHCARE PVT. L | 200 | 15 | Tablet | 1.95 | 22.18% | 5.53 | 0.37 | -- |
-- |
Metronidazole Tablet 200mg | METRON 200 MG TABLET 10 | -- |
ALKEM LABORATORIES LTD. | 200 | 10 | Tablet | 0.31 | 3.57% | 3.62 | 0.36 | -- |
-- |
Metronidazole Tablet 200mg | METGYL 200 MG TABLET 100 | -- |
JAGSONPAL PHARMACEUTIC | 200 | 100 | Tablet | 0.18 | 2.02% | 30.00 | 0.30 | -- |
-- |
Metronidazole Tablet 200mg | METROGYL 200 MG TABLET 15 | -- |
JB CHEMICALS | 200 | 15 | Tablet | 4.30 | 48.90% | 5.53 | 0.37 | -- |
-- |
Metronidazole Tablet 200mg | METROGYL 200 MG TABLET 10 | -- |
JB CHEMICALS | 200 | 10 | Tablet | 1.27 | 14.45% | 3.80 | 0.38 | -- |
-- |
Metronidazole Tablet 200mg | METROGYL 200 MG TABLET 100 | -- |
JB CHEMICALS | 200 | 100 | Tablet | 0.78 | 8.87% | 28.61 | 0.29 | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
8.79 | 100.00% | -- |
0.35 | 0.41 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
maximum | 0.38 | minimum | 0.29 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
As per the above there are 4 companies consisting of Market Share of 1% & Abo | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Sum of MAT value considered for price calculation | 879.00 | (Rs. in lakh) | -- |
-- |
-- |
-- |
-- |
-- |
-- |
||
-- |
Sum of PTR per unit considered for price calculation | 2.07 | -- |
-- |
-- |
-- |
||||||
-- |
Number of Packs considered | 6 | -- |
-- |
||||||||
-- |
Average PTR | 0.35 | -- |
-- |
||||||||
-- |
Add : 16% Retailer Margin | 0.06 | -- |
-- |
||||||||
-- |
Ceiling Price (without local taxes) | 0.41 | -- |
-- |
||||||||
-- |
% Reduction with compared to Highest Price | 7.89% | -- |
-- |
||||||||
-- |
-- |
-- |
-- |
-- |
||||||||
-- |
WPI increase on 1 April, 2015 | 3.849% | -- |
|||||||||
-- |
Ceiling Price after WPI Adjustment (Effective from 01.04.2015) | 0.43 | S.O. No. 834(E) dt. 25.03.2015 | -- |
||||||||
-- |
||||||||||||
| Source of data: Pharma Trac and company | ||||||||||||
| 6.2.2.8.1.2 | Metronidazole Tablet 400 mg | FLAGYL 400 MG TABLET 15 | -- |
ABBOTT HEALTHCARE PVT. L | 400 | 15 | Tablet | 14.46 | 25.86% | 9.78 | 0.65 | -- |
-- |
Metronidazole Tablet 400 mg | METRON FORTE 400 MG TABLET 10 | -- |
ALKEM LABORATORIES LTD. | 400 | 10 | Tablet | 2.70 | 4.82% | 6.4 | 0.64 | -- |
-- |
Metronidazole Tablet 400 mg | METRON 400 MG TABLET 10 | -- |
ALKEM LABORATORIES LTD. | 400 | 10 | Tablet | 0.75 | 1.34% | 6.4 | 0.64 | -- |
-- |
Metronidazole Tablet 400 mg | ARISTOGYL 400 MG TABLET 10 | -- |
ARISTO PHARMACEUTICALS P | 400 | 10 | Tablet | 0.22 | 0.40% | 6.47 | 0.65 | -- |
-- |
Metronidazole Tablet 400 mg | METGYL 400 MG TABLET 100 | -- |
JAGSONPAL PHARMACEUTICA | 400 | 100 | Tablet | 0.15 | 0.27% | 47 | 0.47 | -- |
-- |
Metronidazole Tablet 400 mg | METROGYL 400 MG TABLET 15 | -- |
JB CHEMICALS | 400 | 15 | Tablet | 37.64 | 67.31% | 9.78 | 0.65 | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
55.9 | 100.00% | -- |
0.65 | 0.75 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
maximum | 0.65 | minimum | 0.64 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
As per the above there are 3 companies consisting of Market Share of 1% & Abo | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Sum of MAT value considered for price calculation | 5,554.00 | (Rs. in lakh) | -- |
-- |
-- |
-- |
-- |
-- |
-- |
||
-- |
Sum of PTR per unit considered for price calculation | 2.58 | -- |
-- |
-- |
-- |
||||||
-- |
Number of Packs considered | 4 | -- |
-- |
-- |
|||||||
-- |
Average PTR | 0.65 | -- |
-- |
-- |
|||||||
-- |
Add : 16% Retailer Margin | 0.10 | -- |
-- |
-- |
|||||||
-- |
Ceiling Price (without local taxes) | 0.75 | -- |
-- |
-- |
|||||||
-- |
% Reduction with compared to Highest Price | 0.00% | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
-- |
|||||||
-- |
WPI increase on 1 April, 2015 | 3.849% | -- |
|||||||||
-- |
Ceiling Price after WPI Adjustment (Effective from 01.04.2015) | 0.78 | S.O. No. 834(E) dt. 25.03.2015 | -- |
||||||||
-- |
||||||||||||
-- |
Source of data: Pharma Trac and companies | -- |
||||||||||
-- |
Metronidazole Injection 500mg/100ml | METRONIDAZOLE (ALBERT) 500 MG INF | -- |
ALBERT DAVID | 500 | 100 | ML | 0.13 | 0.68% | 10.25 | 0.10 | -- |
-- |
Metronidazole Injection 500mg/100ml | METRON 500 MG INFUSION 100 ML | -- |
ALKEM LABORATORIES LTD. | 500 | 100 | ML | 4.52 | 24.12% | 10.26 | 0.10 | -- |
-- |
Metronidazole Injection 500mg/100ml | METRIS 500 MG INFUSION 100 ML | -- |
CLARIS LIFESCIENCES LIMIT | 500 | 100 | ML | 0.90 | 4.79% | 9.50 | 0.10 | -- |
-- |
Metronidazole Injection 500mg/100ml | Alemetro I V Inj 100 ml | -- |
Alembic | 500 | 100 | ML | 0.23 | 1.23% | 10.36 | 0.10 | -- |
-- |
Metronidazole Injection 500mg/100ml | METROGYL IV 500 MG INFUSION 100 M | -- |
JB CHEMICALS | 500 | 100 | ML | 12.48 | 66.63% | 10.99 | 0.11 | -- |
-- |
Metronidazole Injection 500mg/100ml | Metronidazole injection IP 100 ml | -- |
Rusoma Lab | 500 | 100 | ML | 0.36 | 1.93% | 12.00 | 0.12 | -- |
-- |
Metronidazole Injection 500mg/100ml | Restrogyl injection 100 ml | -- |
Rusoma Lab | 500 | 100 | ML | 0.12 | 0.62% | 12.00 | 0.12 | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
18.7 | 100.00% | -- |
0.11 | 0.13 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
maximum | 0.12 | minimum | 0.10 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
As per the above there are 6 companies consisting of Market Share of 1% & Abo | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Sum of MAT value considered for price calculation | 1,860.00 | (Rs. in lakh) | -- |
-- |
-- |
-- |
-- |
-- |
-- |
||
-- |
Sum of PTR per unit considered for price calculation | 0.65 | -- |
-- |
-- |
-- |
||||||
-- |
Number of Packs considered | 6 | -- |
-- |
-- |
|||||||
-- |
Average PTR | 0.11 | -- |
-- |
-- |
|||||||
-- |
Add : 16% Retailer Margin | 0.02 | -- |
-- |
-- |
|||||||
-- |
Ceiling Price (without local taxes) | 0.13 | -- |
-- |
-- |
|||||||
-- |
% Reduction with compared to Highest Price | 8.33% | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
-- |
|||||||
-- |
WPI increase on 1 April, 2015 | 3.849% | -- |
|||||||||
-- |
Ceiling Price after WPI Adjustment (Effective from 01.04.2015) | 0.14 | S.O. No. 834(E) dt. 25.03.2015 | -- |
||||||||
Source of data: IMS and companies
| NLEM Unique No. | Composition as per NLEM | PACK_DESC | BRANDS | Company | Strength | Pack size | Unit | MAT Sep’13 Value | MAT% | PTR Sep’13 | Price per Unit |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 17.1.3.1 | RANITIDINE HYDROCHLORIDE | NICOTAC IN | NICOTAC | ABBOTT* | 25 | 2 | ML | 920930 | 0.21% | 1.8 | 0.90 |
-- |
RANITIDINE HYDROCHLORIDE | RAFILON INJ | RAFILON | ALKEM* | 25 | 2 | ML | 233562 | 0.05% | 1.91 | 0.96 |
-- |
RANITIDINE HYDROCHLORIDE | ACILOC INJ | ACILOC | CADILA PHARMA | 25 | 2 | ML | 1.87E+08 | 42.92% | 2.85 | 1.43 |
-- |
RANITIDINE HYDROCHLORIDE | ZINETAC IN | ZINETAC | GLAXOSMITHKLINE* | 25 | 2 | ML | 9302256 | 2.14% | 2.84 | 1.42 |
-- |
RANITIDINE HYDROCHLORIDE | MONOLOC I | MONOLOC | INTAS PHARMA* | 25 | 2 | ML | 405144 | 0.09% | 1.6 | 0.80 |
-- |
RANITIDINE HYDROCHLORIDE | RANLOC INJ | RANLOC | INTAS PHARMA* | 25 | 2 | ML | 2365510 | 0.54% | 1.65 | 0.83 |
-- |
RANITIDINE HYDROCHLORIDE | RANITAS INJ | RANITAS | INTAS PHARMA* | 25 | 2 | ML | 148795 | 0.03% | 1.98 | 0.99 |
-- |
RANITIDINE HYDROCHLORIDE | LANTAC INJ | LANTAC | LABORATE PHARMA | 25 | 2 | ML | 293235.9 | 0.07% | 1.9 | 0.95 |
-- |
RANITIDINE HYDROCHLORIDE | HELKOSS IN | HELKOSS | LUPIN LIMITED | 25 | 2 | ML | 482473 | 0.11% | 2 | 1.00 |
-- |
RANITIDINE HYDROCHLORIDE | RANITIDINE | RANITIDINE | MANKIND | 25 | 2 | ML | 4456000 | 1.02% | 2.63 | 1.32 |
-- |
RANITIDINE HYDROCHLORIDE | HISTAC INJ | HISTAC | RANBAXY* | 25 | 2 | ML | 18732384 | 4.31% | 3.01 | 1.51 |
-- |
RANITIDINE HYDROCHLORIDE | RANIPHAR I | RANIPHAR | RPG LIFE SCIENCES | 25 | 2 | ML | 224585.2 | 0.05% | 1.69 | 0.85 |
-- |
RANITIDINE HYDROCHLORIDE | RANITIN INJ | RANITIN | TORRENT PHARMA | 25 | 2 | ML | 37443004 | 8.61% | 2.85 | 1.43 |
-- |
RANITIDINE HYDROCHLORIDE | RANTAC IN | RANTAC | UNIQUE PHARM | 50 | 2 | ML | 1.02E+08 | 23.54% | 2.8 | 1.40 |
-- |
RANITIDINE HYDROCHLORIDE | RANIPEP INJ | RANIPEP | WOCKHARDT LTD* | 25 | 2 | ML | 1801742 | 0.41% | 2 | 1.00 |
-- |
RANITIDINE HYDROCHLORIDE | BINTAC INJ | BINTAC | ZYDUS CADILA* | 25 | 2 | ML | 1219586 | 0.28% | 1.4 | 0.70 |
-- |
RANITIDINE HYDROCHLORIDE | GERTAC IN | GERTAC | ZYDUS CADILA* | 25 | 2 | ML | 612192 | 0.14% | 2.25 | 1.13 |
-- |
RANITIDINE HYDROCHLORIDE | PEPLOC IN | PEPLOC | ZYDUS CADILA* | 25 | 2 | ML | 432358 | 0.10% | 1.7 | 0.85 |
-- |
RANITIDINE HYDROCHLORIDE | R-LOC INJ | R-LOC | ZYDUS CADILA* | 25 | 2 | ML | 66854854 | 15.37% | 2.89 | 1.45 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
4.35E+08 | 100.00% | -- |
1.26 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
maximum | 1.51 | minimum |
-- |
As per the above there are 7 companies co | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Sum of MAT value considered for price calculation | 4,281.72 | (Rs. in lakh | -- |
-- |
-- |
-- |
-- |
-- |
||
-- |
Sum of PTR per unit considered for price calculation | 12.61 | -- |
-- |
-- |
-- |
|||||
-- |
Number of Packs considered | 10 | -- |
-- |
-- |
-- |
-- |
||||
-- |
Average PTR | 1.26 | -- |
-- |
-- |
-- |
-- |
||||
-- |
Add : 16% Retailer Margin | 0.20 | -- |
-- |
-- |
-- |
-- |
||||
-- |
Ceiling Price (without local taxes) | 1.46 | -- |
-- |
-- |
-- |
-- |
||||
-- |
% Reduction with compared to Highest Price | 17.00% | -- |
-- |
-- |
-- |
-- |
||||
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
||||
-- |
WPI increase on 1 April, 2014 | 6.32% | -- |
-- |
-- |
-- |
-- |
||||
-- |
Ceiling Price after WPI Adjustment (applicable upto 31.03.2015) | 1.55 | -- |
-- |
-- |
-- |
-- |
||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
-- |
WPI increase on 1 April, 2015 | 3.849% | -- |
-- |
-- |
||||||
-- |
Ceiling Price after WPI Adjustment (Effective from 01.04.2015) | 1.61 | S.O. No. 837(E) dt. 25.03.2015 | -- |
-- |
-- |
|||||
| Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Unit | Dosage Form | Pack Size | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | – | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.2.3.3 | Lignocaine Hydrochloride Spinal 5% + 7.5% Glucose |
Neon Laboratories Ltd. | Lox 5% Heav | ml | Spinal Injection | 2 | 12.70 | ###### | 100.00% | 6.35 | -- |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|
-- |
Monopoly situation as only M/s. Neon Laboratories Ltd. is the known man | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|
-- |
PTR per unit | -- |
6.35 | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|
-- |
Price fixed in the relevant sub-section for other similar drugs is as follows | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|
-- |
Section: 1 Anesthesia | -- |
-- |
-- |
-- |
-- |
||||||
-- |
1.2: Local Anesthetics | -- |
-- |
-- |
-- |
-- |
||||||
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | Unit Ceiling Price (Rs.) | Meeting No. | S.O. No. | Date | % Reduction w.r.t. Highest Price | -- |
-- |
|
-- |
Lignocaine Hydrochloride | P,S,T | Topical Forms | 2-5% | 1.18 | 7th | 2854 | 20.09.2013 | 41.24 | -- |
||
-- |
Lignocaine Hydrochloride | P,S,T | Injection | 1% | 6.87 | 8th | 3376 | 05.11.2013 | 49.41 | -- |
||
-- |
Lignocaine Hydrochloride | P,S,T | Injection | 2% | 1.00 | 5th | 2248 | 22.07.2013 | 49.41 | -- |
||
-- |
Lignocaine Hydrochloride | P,S,T | Spinal | 5% + 7.5% Glucose | Under consideration | -- |
-- |
-- |
-- |
-- |
||
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Average Reduction | 46.69 | -- |
|||
-- |
||||||||||||
-- |
Therefore, PTR per unit | 6.35X (1-46.49%) | -- |
-- |
3.39 | -- |
||||||
-- |
Add: 16% Retailer Margin | -- |
-- |
-- |
0.54 | -- |
-- |
-- |
||||
-- |
Ceiling Price per unit | -- |
-- |
-- |
3.93 | -- |
||||||
-- |
WPI factor @ 6.32% | -- |
-- |
-- |
-- |
0.25 | -- |
|||||
-- |
Ceiling Price (including WPI but without local taxes) | -- |
-- |
4.18 | -- |
|||||||
-- |
WPI factor @ 3.849% | -- |
-- |
-- |
-- |
0.16 | -- |
|||||
-- |
Revised Ceiling Price (including WPI but without local taxes) | -- |
4.34 | S.O. No. 835(E) dt. 25.03.2015 | -- |
|||||||
-- |
(W.E.f form 01.04.2015) | -- |
||||||||||
-- |
||||||||||||
| 4.2.2.1 | Polyvalent Antisnake Venom – Polyvalent | Biological E. Limited | Anti Sanke | Liquid (1 vial of 10 ml) | vial | 1 | 316.95 | ##### | 36.57% | 316.95 | -- |
-- |
-- |
-- |
Bharat Serum | Anake veno | -- |
vial | 1 | 440.00 | ##### | 63.43% | 440.00 | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
##### | 100.00% | 378.48 | 439.04 | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
maximum | 440.00 | minimum | 316.95 | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
||||||
-- |
As per the above there are 2 companies consisting of Market Share of 1% & Above | -- |
-- |
-- |
-- |
|||||||
-- |
Sum of MAT value considered for price calculation | -- |
-- |
-- |
-- |
964.78 | (In Lakh) | -- |
-- |
-- |
-- |
|
-- |
Sum of PTR per unit considered for price calculation | -- |
-- |
-- |
-- |
756.95 | -- |
-- |
-- |
-- |
-- |
|
-- |
Number of Packs considered | -- |
-- |
-- |
-- |
2 | -- |
-- |
-- |
-- |
||
-- |
Ceiling Price | -- |
-- |
-- |
-- |
378.48 | -- |
-- |
-- |
-- |
||
-- |
Add : 16% Retailer Margin | -- |
-- |
-- |
-- |
60.56 | -- |
-- |
-- |
-- |
||
-- |
MRP (without local taxes) | -- |
-- |
-- |
-- |
439.04 | -- |
-- |
-- |
-- |
||
-- |
% Reduction with compared to Highest Price | -- |
-- |
-- |
-- |
13.98% | -- |
-- |
-- |
-- |
||
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|||
-- |
WPI factor @ 6.32% | -- |
-- |
27.75 | -- |
-- |
||||||
-- |
Revised Ceiling Price (including WPI but without local taxes) wef 01.4.2014 | -- |
-- |
466.79 | -- |
-- |
||||||
-- |
-- |
-- |
-- |
-- |
-- |
-- |
||||||
-- |
WPI factor @ 3.849% | -- |
-- |
17.97 | -- |
-- |
||||||
-- |
Revised Ceiling Price (including WPI but without local taxes) wef 01.4.2015 | -- |
-- |
484.76 | S.O. No. 838(E) dt. 25.03.2015 | -- |
-- |
|||||
-- |
||||||||||||
| 4.2.2.1 | Polyvalent Antisnake Venom-Lyophilized | Haffkine Bio-Pharmaceutical Corporatio | Snake Antiv | Lyophilized (I vial of 10 ml) | vial | 1 | 436.83 | ##### | 18.65% | 436.83 | -- |
-- |
-- |
-- |
Serum Institute of India | Sanke Antiv | Freeze- Dried | vial | 1 | 365.60 | ##### | 0.74% | 365.60 | -- |
-- |
-- |
-- |
Bharat Serum | Snake veno | Lyophilized (I vial of 10 ml) | vial | 1 | 480.00 | ##### | 16.69% | 480.00 | -- |
-- |
-- |
-- |
Vins Bioproducts Limited | Snake Venu | Lyophilized (I vial of 10 ml) | vial | 1 | 462.00 | ##### | 63.92% | 462.00 | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
##### | 100.00% | 459.61 | 533.15 | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
maximum | 480.00 | minimum | 436.83 | -- |
-- |
As per the above there are 3 companies consisting of Market Share of 1% & Above | -- |
-- |
-- |
-- |
|||||||
-- |
Sum of MAT value considered for price calculation | -- |
-- |
-- |
-- |
2274.10 | (In Lakh) | -- |
-- |
-- |
-- |
|
-- |
Sum of PTR per unit considered for price calculation | -- |
-- |
-- |
-- |
1378.83 | -- |
-- |
-- |
-- |
-- |
|
-- |
Number of Packs considered | -- |
-- |
-- |
-- |
3 | -- |
-- |
-- |
-- |
||
-- |
Ceiling Price | -- |
-- |
-- |
-- |
459.61 | -- |
-- |
-- |
-- |
||
-- |
Add : 16% Retailer Margin | -- |
-- |
-- |
-- |
73.54 | -- |
-- |
-- |
-- |
||
-- |
MRP (without local taxes) | -- |
-- |
-- |
-- |
533.15 | -- |
-- |
-- |
-- |
||
-- |
% Reduction with compared to Highest Price | -- |
-- |
-- |
-- |
4.25% | -- |
-- |
-- |
-- |
||
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|||
-- |
WPI factor @ 6.32% | -- |
-- |
33.70 | -- |
-- |
||||||
-- |
Revised Ceiling Price (including WPI but without local taxes) wef 01.4.2014 | -- |
-- |
566.85 | -- |
-- |
||||||
-- |
-- |
-- |
-- |
-- |
-- |
-- |
||||||
-- |
WPI factor @ 3.849% | -- |
-- |
21.82 | -- |
-- |
||||||
-- |
Revised Ceiling Price (including WPI but without local taxes) wef 01.4.2015 | -- |
-- |
588.67 | S.O. No. 838(E) dt. 25.03.2015 | -- |
-- |
|||||
-- |
||||||||||||
| 19.2.5.1 | Rabies Immunoglobin 150 IU/ml | Bharat Serum and vaccines Ltd. | Berirab-P | 2ml ampoule | Injection | 2 | ml | ##### | ####### | 17.94% | 2095.24 | -- |
| 19.2.5.1 | Rabies Immunoglobin 150 IU/ml | Synergy Diagnostics Pvt. Ltd. | KamRAB | 2ml vial | Injection | 2 | ml | ##### | ####### | 82.06% | 2797.00 | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
####### | ###### | 2446.12 | 2837.50 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
maximum | 2797.00 | minimum | 2095.24 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
As per the above there are 2 companies consisting of Market Share of 1% & Above | -- |
-- |
-- |
-- |
|||||||
-- |
Sum of MAT value considered for price calculation | -- |
-- |
-- |
-- |
1755.59 | (In Lakh) | -- |
-- |
-- |
||
-- |
Sum of PTR per unit considered for price calculation | -- |
-- |
-- |
-- |
4892.24 | -- |
-- |
-- |
-- |
-- |
|
-- |
Number of Packs considered | -- |
-- |
-- |
-- |
2 | -- |
-- |
-- |
-- |
||
-- |
Ceiling Price | -- |
-- |
-- |
-- |
2446.12 | -- |
-- |
-- |
-- |
||
-- |
Add : 16% Retailer Margin | -- |
-- |
-- |
-- |
391.38 | -- |
-- |
-- |
-- |
||
-- |
MRP (without local taxes) | -- |
-- |
-- |
-- |
2837.50 | -- |
-- |
-- |
-- |
||
-- |
% Reduction with compared to Highest Price | -- |
-- |
-- |
-- |
12.54% | -- |
-- |
-- |
-- |
||
-- |
WPI factor @ 6.32% | -- |
-- |
179.33 | -- |
-- |
||||||
-- |
Revised Ceiling Price (including WPI but without local taxes) | -- |
-- |
3016.83 | -- |
-- |
||||||
-- |
WPI factor @ 3.849% | -- |
-- |
116.12 | -- |
-- |
||||||
-- |
Revised Ceiling Price (including WPI but without local taxes) | -- |
-- |
3132.95 | S.O. No. 839(E) dt. 25.03.2015 | -- |
||||||
| Unique N | Composition as per NLEM | Pack Description | BRANDS | Company | Strength | Pack Size | Unit | MAT Value as on 30th Sept. 2013 | MAT % | PTR | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.2.2.4 & 6.5.4.3 | Co-Trimoxazole (Trimethoprim + SulphamethoxaZole) Suspension 40 + 200 mg | ANTRIMA SUSP PAED 200 MG 50 ML x 1 (/ | ANTRIMA | ABBOTT HEALTHCARE | 200/40 | 50 | ML | 2E+06 | 1.71% | 11.59 | 0.23 | -- |
-- |
Co-Trimoxazole (Trimethoprim + SulphamethoxaZole) Suspension 40 + 200 mg | BACTRIM SUSP 240 MG 50 ML x 1 (/5ML) | BACTRIM | ABBOTT HEALTHCARE | 240 | 50 | ML | 2E+07 | 13.66% | 11.59 | 0.23 | -- |
-- |
Co-Trimoxazole (Trimethoprim + SulphamethoxaZole) Suspension 40 + 200 mg | CIPLIN SUSP 40 MG 50 ML x 1 (/200) | CIPLIN | CIPLA | 200/40 | 50 | ML | 34241 | 0.03% | 9.56 | 0.19 | -- |
-- |
Co-Trimoxazole (Trimethoprim + SulphamethoxaZole) Suspension 40 + 200 mg | LARPRIM SUSP 240 MG 50 ML x 1 (/5ML) | LARPRIM | LARK LABS | 240 | 50 | ML | 268488 | 0.20% | 10.16 | 0.20 | -- |
-- |
Co-Trimoxazole (Trimethoprim + SulphamethoxaZole) Suspension 40 + 200 mg | ORIPRIM SUSP 200 MG 50 ML x 1 (/40) | ORIPRIM | ZYDUS CADILA | 200/40 | 50 | ML | 2E+06 | 1.19% | 10.59 | 0.21 | -- |
-- |
Co-Trimoxazole (Trimethoprim + SulphamethoxaZole) Suspension 40 + 200 mg | SEPTRAN SUSP PAED 40 MG 50 ML x 1 (/ | SEPTRAN | GLAXOSMITHKLINE | 200/40 | 50 | ML | 1E+08 | 83.18% | 10.50 | 0.21 | -- |
-- |
Co-Trimoxazole (Trimethoprim + SulphamethoxaZole) Suspension 40 + 200 mg | KELTRIM SUSPENSION | KELTRIM | BESCOAT | 200/40 | 50 | ML | 31010 | 0.02% | 10.32 | 0.21 | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
1E+08 | 100.00% | -- |
0.22 | 0.26 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
maximum | 0.23 | minimum | 0.21 | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
||||
-- |
As per the above there are 3 companies consisting of Market Share of 1% & Above | -- |
-- |
-- |
-- |
-- |
||||||
-- |
Sum of MAT value considered for price calculation | -- |
1310.28 | (Rs. In Lakhs) | -- |
-- |
-- |
-- |
-- |
|||
-- |
Sum of PTR per unit considered for price calculation | -- |
0.88 | -- |
-- |
-- |
-- |
-- |
-- |
|||
-- |
Number of Packs considered | -- |
4 | -- |
-- |
-- |
-- |
-- |
-- |
|||
-- |
Ceiling Price | -- |
0.22 | -- |
-- |
-- |
-- |
-- |
-- |
|||
-- |
Add : 16% Retailer Margin | -- |
0.04 | -- |
-- |
-- |
-- |
-- |
-- |
|||
-- |
MRP (without local taxes) | -- |
0.26 | -- |
-- |
-- |
-- |
-- |
-- |
|||
-- |
% Reduction with compared to Highest Price | -- |
4.35% | -- |
-- |
-- |
-- |
-- |
-- |
|||
-- |
WPI factor @ 6.32% | -- |
-- |
0.02 | -- |
-- |
-- |
-- |
-- |
-- |
||
-- |
Revised Ceiling Price (including WPI but without local taxes) | -- |
0.28 | -- |
-- |
-- |
-- |
-- |
-- |
|||
-- |
WPI factor @ 3.849% | -- |
-- |
0.01 | -- |
-- |
-- |
-- |
-- |
-- |
||
-- |
Revised Ceiling Price (including WPI but without local taxes) w.e.f 01.04.2015 | -- |
0.29 | -- |
S.O. No. 840(E) dt. 25.03.2015 | -- |
-- |
|||||
Source of Data – Pharma Trac (May, 2014)
| S.No. | Composition of the Product | Company | Dosage Form | Pack size | Price to Retailer (Rs.) | MAT Value | MAT % | Price per unit | Retail Price with 16 % Margin |
|---|---|---|---|---|---|---|---|---|---|
-- |
Stezone SB-375 Each vial Contains: Sterile Ceftriaxone Sodium eq. to Ceftriaxone Ip 250 mg Sterile Sulbactam sodium eq. to Sulbactum USP 125 mg |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
| 1 | EFFIMAX S 250/125 MG INJECTION 10 ML | ABBOTT HEALTHCARE PVT. LTD | Injection | 1 | 29.33 | 47074598.41 | 17.42% | 29.33 | -- |
| 2 | PANCEF S 250/125 MG INJECTION 2 ML | AGLOWMED PHARMACEUTICALS LTD. | Injection | 1 | 34.29 | 113744.79 | 0.04% | 34.29 | -- |
| 3 | CEFAST MAX 250/125 MG INJECTION 1 | ALKEM LABORATORIES LTD. | Injection | 1 | 35.34 | 2687041.56 | 0.99% | 35.34 | -- |
| 4 | CEFPRA S 250/125 MG INJECTION 1 | AMPRA PHARMACEUTICALS | Injection | 1 | 33.10 | 414872.60 | 0.15% | 33.10 | -- |
| 5 | MONOCEF SB 250/125 MG INJECTION 1 | ARISTO PHARMACEUTICALS PVT.LTD | Injection | 1 | 34.65 | 18266717.70 | 6.76% | 34.65 | -- |
| 6 | BENOKING 250/125 MG INJECTION 1 | BENNET PHARMACEUTICALS LIMITED | Injection | 1 | 32.00 | 810016.00 | 0.30% | 32.00 | -- |
| 7 | BIG TUM 250/125 MG INJECTION 10 ML | BESTOCHEM FORMULATIONS (I) LTD | Injection | 1 | 36.19 | 12436646.30 | 4.60% | 36.19 | -- |
| 8 | MONOTAX SB 250/125 MG INJECTION 1 | BIOCHEM PHARMACEUTICAL INDS | Injection | 1 | 23.24 | 4027584.96 | 1.49% | 23.24 | -- |
| 9 | EXTACEF XL 250/125 MG INJECTION 5 ML | BLUE CROSS LABORATORIES LTD | Injection | 1 | 29.71 | 2341207.42 | 0.87% | 29.71 | -- |
| 10 | TRAXOL S 250/125 MG INJECTION 10 ML | CACHET PHARMACEUTICALS PVT LTD | Injection | 1 | 35.05 | 50948174.66 | 18.86% | 35.05 | -- |
| 11 | CEFBACT S 250/125 MG INJECTION 5 ML | CIPLA LTD. | Injection | 1 | 37.70 | 279638.60 | 0.10% | 37.70 | -- |
| 12 | CORCEF SB 250/125 MG INJECTION 1 | CORONA | Injection | 1 | 29.58 | 99094.12 | 0.04% | 29.58 | -- |
| 13 | FORMIC 250/125 MG INJECTION 10 ML | ELDER PHARMACEUTICALS LTD | Injection | 1 | 35.05 | 4383282.90 | 1.62% | 35.05 | -- |
| 14 | ODICEF S 250/125 MG INJECTION 2 ML | GALPHA LABORATORIES LTD | Injection | 1 | 34.29 | 14029684.92 | 5.19% | 34.29 | -- |
| 15 | MILIBACT 250/125 MG INJECTION 5 ML | GLENMARK PHARMACEUTICALS LTD. | Injection | 1 | 37.56 | 10015111.08 | 3.71% | 37.56 | -- |
| 16 | CESAFE SM 250/125 MG INJECTION 1 ML | GUJARAT TERCE LABORATORIES LTD | Injection | 1 | 28.19 | 428488.00 | 0.16% | 28.19 | -- |
| 17 | KEFTRAGARD 250/125 MG INJECTION 5 ML | IPCA LABORATORIES PVT LTD. | Injection | 1 | 36.21 | 3121161.07 | 1.16% | 36.21 | -- |
| 18 | CEBACTUM 250/125 MG INJECTION 1 | LEBEN LABORATORIES PVT.LTD | Injection | 1 | 30.81 | 635813.44 | 0.24% | 30.81 | -- |
| 19 | TRIXON S 250/125 MG INJECTION 5 ML | LINCOLN PHARMACEUTICALS LTD | Injection | 1 | 32.53 | 3950113.41 | 1.46% | 32.53 | -- |
| 20 | CEFRINE PLUS 250/125 MG INJECTION 5 ML | MACLEODS PHARMACEUTICALS PVT.LTD | Injection | 1 | 31.24 | 10041164.54 | 3.72% | 31.24 | -- |
| 21 | MACZONE PLUS 250/125 MG INJECTION 5 ML | MACLEODS PHARMACEUTICALS PVT.LTD | Injection | 1 | 31.24 | 7955034.12 | 2.94% | 31.24 | -- |
| 22 | ACCUZON PLUS 250/125 MG INJECTION 1 | MACLEODS PHARMACEUTICALS PVT.LTD | Injection | 1 | 31.24 | 5096443.88 | 1.89% | 31.24 | -- |
| 23 | MAHACEF-SB 250/125 MG INJECTION 1 ML | MANKIND PHARMACEUTICALS LTD. | Injection | 1 | 32.00 | 7683392.00 | 2.84% | 32.00 | -- |
| 24 | GRAMOCEF S 250/125 MG INJECTION 1 | MICRO LABS LTD | Injection | 1 | 32.34 | 898081.80 | 0.33% | 32.34 | -- |
| 25 | CEFPEN S 250/125 MG INJECTION 10 ML | MOREPEN LABORATORIES LIMITED | Injection | 1 | 33.90 | 110886.90 | 0.04% | 33.90 | -- |
| 26 | OFRAMAX FORTE 250/125 MG INJECTION 5 ML | RANBAXY LABORATORIES LTD | Injection | 1 | 36.58 | 11859628.43 | 4.39% | 36.58 | -- |
| 27 | I TAX S 250/125 MG INJECTION 2 ML | SANJIVINI BIOTECH PRIVATE LIMITED | Injection | 1 | 38.89 | 233651.12 | 0.09% | 38.89 | -- |
| 28 | XTUM 250/125 MG INJECTION 1 | SHREYA LIFE SCIENCES PVT. LTD | Injection | 1 | 37.68 | 7641188.51 | 2.83% | 37.68 | -- |
| 29 | CEFERA S 250/125 MG INJECTION 1 | SHREYA LIFE SCIENCES PVT. LTD | Injection | 1 | 37.52 | 2836332.60 | 1.05% | 37.52 | -- |
| 30 | ANCEF SB 250/125 MG INJECTION 1 | SHRINIVAS GUJARAT LABORATORIES PVT LT | Injection | 1 | 36.95 | 1509030.46 | 0.56% | 36.95 | -- |
| 31 | ANCEF SB KID 250/125 MG INJECTION 1 | SHRINIVAS GUJARAT LABORATORIES PVT LT | Injection | 1 | 28.46 | 494051.12 | 0.18% | 28.46 | -- |
| 32 | WAVOCEF S 250/125 MG INJECTION 1 | WAVES BIOTECH PVT. LTD. | Injection | 1 | 36.00 | 918936.00 | 0.34% | 36.00 | -- |
| 33 | MONOBACT 250/125 MG INJECTION 5 ML | ZUVENTUS HEALTHCARE LTD | Injection | 1 | 37.15 | 25867671.85 | 9.57% | 37.15 | -- |
| 34 | MONOBACT KID 250/125 MG INJECTION 5 ML | ZUVENTUS HEALTHCARE LTD | Injection | 1 | 26.22 | 10993231.97 | 4.07% | 26.22 | -- |
-- |
-- |
-- |
-- |
-- |
-- |
270,201,717 | 100.00% | 33.42 | 38.77 |
-- |
-- |
-- |
-- |
-- |
-- |
Maximum | 37.68 | Minimum | 23.24 |
-- |
-- |
-- |
-- |
-- |
|||||
-- |
As per the above there are 15 companies consisting of Market Share of 1% & Above | -- |
|||||||
-- |
Sum of MAT value considered for price calculation | -- |
-- |
2582.27 | (Rs. in Lakhs) | -- |
|||
-- |
Sum of PTR per unit considered for price calculation | -- |
-- |
634.97 | -- |
-- |
|||
-- |
Number of Packs considered | -- |
-- |
19 | -- |
-- |
|||
-- |
Retail Price | -- |
-- |
33.42 | -- |
-- |
|||
-- |
Add : 16% Retailer Margin | -- |
-- |
5.35 | -- |
-- |
|||
-- |
MRP (without local taxes) | -- |
-- |
38.77 | S.O. No. 841(E) dt. 25.03.2015 | -- |
|||
-- |
% Reduction with compared to Highest Price | -- |
-- |
11.31% | -- |
-- |
|||
| Source of Data-Pharma Trac , May’14 | |||||||||
-- |
Amoxycillin & Dicloxacillin Capsule Each Hard gelatin capsule contains: Amoxycillin Trihydrate eq. to Amoxycillin 250 mg Dicloxacillin Sodium eq. to Dicloxacillin 250 mg |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
| 1 | MEGAMOX DX 250/250 MG CAPSULE 10 | ABBOTT HEALTHCARE PVT. LTD | Capsule | 10 | 48.61 | 12052509.23 | 10.96% | 4.86 | -- |
| 2 | BACIMOX NEW 250/250 MG CAPSULE 6 | ALEMBIC LTD | Capsule | 6 | 30.02 | 1209751.24 | 1.10% | 5.00 | -- |
| 3 | PENOM DX 250/250 MG CAPSULE 10 | APOSTLE REMEDIES | Capsule | 10 | 34.65 | 477515.25 | 0.43% | 3.47 | -- |
| 4 | BLUMOX DXL 250/250 MG CAPSULE 6 | BLUE CROSS LABORATORIES LTD | Capsule | 6 | 25.14 | 23280181.14 | 21.16% | 4.19 | -- |
| 5 | CYCLOX (CALIBAR) 250/250 MG CAPSULE 10 | CALIBAR PHARMACEUTICALS | Capsule | 10 | 69.31 | 137555.84 | 0.13% | 6.93 | -- |
| 6 | ABCLOX 250/250 MG CAPSULE 10 | CENTAUR PHARMACEUTICALS PVT.LTD | Capsule | 10 | 49.19 | 5462802.43 | 4.97% | 4.92 | -- |
| 7 | SPORCLOX 250/250 MG CAPSULE 10 | DIAL PHARMACEUTICALS PVT. LTD. | Capsule | 10 | 49.52 | 315316.58 | 0.29% | 4.95 | -- |
| 8 | CLODAX 250/250 MG CAPSULE 10 | DWD PHARMACEUTICALS LTD | Capsule | 10 | 38.10 | 1422082.50 | 1.29% | 3.81 | -- |
| 9 | FLEMIKLOX DX 250/250 MG CAPSULE 10 | FDC LTD. | Capsule | 10 | 50.29 | 55040.28 | 0.05% | 5.03 | -- |
| 10 | FLEMIKLOX 250/250 MG CAPSULE 10 | FDC LTD. | Capsule | 10 | 50.29 | 18777.79 | 0.02% | 5.03 | -- |
| 11 | AMOTOX DC 250/250 MG CAPSULE 6 | FRANKLIN LABORATORIES (INDIA) PVT. LTD. | Capsule | 6 | 15.30 | 46725.30 | 0.04% | 2.55 | -- |
| 12 | MOXIKIND PLUS 250/250 MG CAPSULE 10 | MANKIND PHARMACEUTICALS LTD. | Capsule | 10 | 47.62 | 21595670.00 | 19.63% | 4.76 | -- |
| 13 | CLYNOX 250/250 MG CAPSULE 10 | MICRO LABS LTD | Capsule | 10 | 43.89 | 1214996.91 | 1.10% | 4.39 | -- |
| 14 | BONCLOX 250/250 MG CAPSULE 10 | PEGASUS FARMACO INDIA PVT. LTD. | Capsule | 10 | 37.99 | 140900.59 | 0.13% | 3.80 | -- |
| 15 | AMX DC 250/250 MG CAPSULE 10 | RANBAXY LABORATORIES LTD | Capsule | 10 | 29.50 | 129505.40 | 0.12% | 2.95 | -- |
| 16 | SB CLOX 250/250 MG CAPSULE 10 | SIMPSON & BRAWN PHARMACEUTICALS | Capsule | 10 | 46.98 | 381112.47 | 0.35% | 4.70 | -- |
| 17 | AMPOXIN PLUS 250/250 MG CAPSULE 10 | UNICHEM LABORATORIES LTD | Capsule | 10 | 46.10 | 30898285.76 | 28.09% | 4.61 | -- |
| 18 | REDCLOX D 250/250 MG CAPSULE 9 | ZYDUS CADILA | Capsule | 9 | 35.66 | 11175166.46 | 10.16% | 3.96 | -- |
-- |
-- |
-- |
-- |
-- |
-- |
110013895.17 | 100.00% | 4.50 | 5.22 |
-- |
-- |
-- |
-- |
-- |
-- |
Maximum | 5.00 | Minimu | 3.81 |
-- |
-- |
-- |
-- |
||||||
-- |
As per the above there are 9 companies consisting of Market Share of 1% & Above | -- |
-- |
||||||
-- |
Sum of MAT value considered for price calculation | -- |
-- |
1083.11 | (Rs. in Lakhs) | -- |
|||
-- |
Sum of PTR per unit considered for price calculation | -- |
-- |
40.50 | -- |
-- |
|||
-- |
Number of Packs considered | -- |
-- |
9 | -- |
-- |
|||
-- |
Retail Price | -- |
-- |
4.50 | -- |
-- |
|||
-- |
Add : 16% Retailer Margin | -- |
-- |
0.72 | -- |
-- |
|||
-- |
MRP (without local taxes) | -- |
-- |
5.22 | S.O. No. 841(E) dt. 25.03.2015 | -- |
|||
-- |
% Reduction with compared to Highest Price | -- |
-- |
10.00% | -- |
-- |
|||
| Source of Data-Pharma Trac ( April’ 2014) | |||||||||
-- |
Novafex Drops Each ml of reconstitution contains: Cefixime eq. to Anhydrous Cefixime 25 mg |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
| 1 | TAXIM O 25 MG DROPS 10 ML | ALKEM LABORATORIES LTD. | Drops | 10 | 35.42 | 60755890 | 45.11% | 3.54 | -- |
| 2 | ZIFI 25 MG DROPS 10 ML | FDC LTD. | Drops | 10 | 31.81 | 17169257 | 12.75% | 3.18 | -- |
| 3 | C TAX O 25 MG DROPS 10 ML | ZUVENTUS HEALTHCARE LTD | Drops | 10 | 32.57 | 6464689 | 4.80% | 3.26 | -- |
| 4 | TAXONE O 25 MG DROPS 10 ML | MAPRA LABORATORIES PVT. LTD | Drops | 10 | 32.57 | 6272656 | 4.66% | 3.26 | -- |
| 5 | TRAXOL O 25 MG DROPS 10 ML | CACHET PHARMACEUTICALS PVT LTD | Drops | 10 | 30.8 | 5560324 | 4.13% | 3.08 | -- |
| 6 | HIFEN 25 MG DROPS 10 ML | HETERO HEALTHCARE LTD | Drops | 10 | 32.38 | 4772585 | 3.54% | 3.24 | -- |
| 7 | CEFOLAC 25 MG DROPS 10 ML | MACLEODS PHARMACEUTICALS PVT.LTD | Drops | 10 | 27.92 | 1485792 | 1.10% | 2.79 | -- |
| 8 | MAHACEF DROPS | INDUS DRUGS PVT. LTD. | Drops | 10 | 32.00 | 32200000 | 23.91% | 3.20 | -- |
-- |
-- |
-- |
-- |
134,681,193 | ###### | 3.19 | 3.70 | ||
-- |
-- |
-- |
-- |
-- |
Maximum | 3.54 | Minimum | 2.79 | |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|||
-- |
As per the above there are 8 companies consisting of Market Share of 1% & Above | -- |
-- |
-- |
-- |
||||
-- |
Sum of MAT value considered for price calculation | -- |
-- |
1,346.81 | (Rs. in Lakhs) | -- |
-- |
||
-- |
Sum of PTR per unit considered for price calculation | -- |
-- |
25.55 | -- |
-- |
-- |
||
-- |
Number of Packs considered | -- |
-- |
8 | -- |
-- |
-- |
||
-- |
Retail Price | -- |
-- |
3.19 | -- |
-- |
-- |
||
-- |
Add : 16% Retailer Margin | -- |
-- |
0.51 | -- |
-- |
-- |
||
-- |
MRP (without local taxes) | -- |
-- |
3.70 | S.O. No. 844(E) dt. 25.03.2015 | -- |
|||
-- |
% Reduction with compared to Highest Price | -- |
-- |
9.89% | -- |
-- |
-- |
||
-- |
Price for 10 ml bottle | (3.70*10) | -- |
37.00 | -- |
-- |
-- |
||
Source of Data-Pharma Trac , May’2014
| S.No. | Composition of the formulation | Company | Pack Descriptions | Dosage Form | Pack size | Price to Retailer (Rs.) | MAT Value | MAT % | Price per tablet | Retail Price with 16 % Margin |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IVAFIX-DX Each film coated tablet contains: Cefixime Trihydrate eq. to Cefixime Anhydrous 200 mg Dicloxacillin Sodium eq. to Dicloxacillin 500 mg (As extended release form) |
ABBOTT HEALTHCARE PVT. LTD | ASERT D 20 | Tablet | 10 | 142.48 | ####### | ###### | 14.25 | -- |
| 2 | MICRO LABS LTD | CEFGLOBE | Tablet | 10 | 121.90 | ####### | ###### | 12.19 | -- |
|
| 3 | ABBOTT HEALTHCARE PVT. LTD | CEFI XL D 2 | Tablet | 10 | 97.52 | ####### | ###### | 9.75 | -- |
|
-- |
-- |
-- |
-- |
###### | ##### | 12.06 | 13.99 | |||
-- |
-- |
-- |
-- |
Maximu | 14.25 | Minimum | 9.75 | |||
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|||
-- |
As per the above there are 3 companies consisting of Market Share of 1% & Above | -- |
-- |
-- |
-- |
-- |
||||
-- |
Sum of MAT value considered for price calculation | -- |
-- |
-- |
881.24 | (Rs. in Lakhs) | -- |
|||
-- |
Sum of PTR per unit considered for price calculation | -- |
-- |
-- |
36.19 | -- |
-- |
|||
-- |
Number of Packs considered | -- |
-- |
-- |
3 | -- |
-- |
|||
-- |
Retail Price | -- |
-- |
-- |
12.06 | -- |
-- |
|||
-- |
Add : 16% Retailer Margin | -- |
-- |
-- |
1.93 | -- |
-- |
|||
-- |
MRP (without local taxes) | -- |
-- |
-- |
13.99 | S.O. No. 841(E) dt. 25.03.2015 | -- |
|||
-- |
% Reduction with compared to Highest Price | -- |
-- |
-- |
15.37% | -- |
-- |
|||
Source of Data – Pharma Trac (June, 2014)
| S.No. | Composition of the Product | Company | Dosage Form | Pack size | Price to Retailer (Rs.) | MAT Value | MAT % | Price per unit | Retail Price with 16 % Margin |
|---|---|---|---|---|---|---|---|---|---|
-- |
Xone SB 1 GM Each vial Contains: Ceftriaxone Sodium eq. to Ceftriaxone Ip 1000 mg Sulbactam Sodium eq. to Sulbactum USP 500 mg |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
| 1 | EFFIMAX S 1000/500 MG INJECTION 10 ML | ABBOTT HEALTHCARE PVT. LTD | Injection | 1 | 82.97 | 151930827.78 | 8.80% | 82.97 | -- |
| 2 | C ONE SB 1000/500 MG INJECTION 1 | ABBOTT HEALTHCARE PVT. LTD | Injection | 1 | 28.00 | 553318.00 | 0.03% | 28.00 | -- |
| 3 | PANCEF S 1000/500 MG INJECTION 10 ML | AGLOWMED PHARMACEUTICALS LTD. | Injection | 1 | 87.62 | 18385742.70 | 1.07% | 87.62 | -- |
| 4 | ATICEF 1000/500 MG INJECTION 1 | ALGEN HEALTHCARE PVT LTD | Injection | 1 | 68.00 | 961642.72 | 0.06% | 68.00 | -- |
| 5 | CEFAST MAX 1000/500 MG INJECTION 1 | ALKEM LABORATORIES LTD. | Injection | 1 | 92.89 | 4523185.66 | 0.26% | 92.89 | -- |
| 6 | CEFPRA S 1000/500 MG INJECTION 1 | AMPRA PHARMACEUTICALS | Injection | 1 | 81.82 | 1433731.86 | 0.08% | 81.82 | -- |
| 7 | MONOCEF SB 1000/500 MG INJECTION 1 | ARISTO PHARMACEUTICALS PVT.LTD | Injection | 1 | 91.62 | 161572328.10 | 9.36% | 91.62 | -- |
| 8 | ROKCEF 1000/500 MG INJECTION 1 | ASTRUM HEALTHCARE PVT. LTD. | Injection | 1 | 100.57 | 388401.34 | 0.02% | 100.57 | -- |
| 9 | BIG TUM 1000/500 MG INJECTION 1 | BESTOCHEM FORMULATIONS (I) LTD | Injection | 1 | 88.79 | 209896137.22 | 12.16% | 88.79 | -- |
| 10 | MONOTAX SB 1000/500 MG INJECTION 1 | BIOCHEM PHARMACEUTICAL INDS | Injection | 1 | 54.23 | 55292257.24 | 3.20% | 54.23 | -- |
| 11 | EXTACEF XL 1000/500 MG INJECTION 10 ML | BLUE CROSS LABORATORIES LTD | Injection | 1 | 32.00 | 34114560.00 | 1.98% | 32.00 | -- |
| 12 | TRAXOL S 1000/500 MG INJECTION 5 ML | CACHET PHARMACEUTICALS PVT LTD | Injection | 1 | 95.24 | 160724536.90 | 9.31% | 95.24 | -- |
| 13 | COMTRIX S 1000/500 MG INJECTION 20 ML | COMED CHEMICALS PVT LTD | Injection | 1 | 83.81 | 13549064.25 | 0.78% | 83.81 | -- |
| 14 | C FORTE 1000/500 MG INJECTION 1 | CONCEPT PHARMACEUTICALS LTD | Injection | 1 | 59.10 | 11307241.50 | 0.66% | 59.10 | -- |
| 15 | CORCEF SB 1000/500 MG INJECTION 2 ML | CORONA | Injection | 1 | 75.43 | 12650365.30 | 0.73% | 75.43 | -- |
| 16 | OXY S 1000/500 MG INJECTION 1 | DR. JOHNS LABORATORIES PVT LTD | Injection | 1 | 93.38 | 2646175.32 | 0.15% | 93.38 | -- |
| 17 | XOY-S 1000/500 MG INJECTION 1 | DR. JOHNS LABORATORIES PVT LTD | Injection | 1 | 96.00 | 1557968.40 | 0.09% | 96.00 | -- |
| 18 | FORMIC 1000/500 MG INJECTION 1 | ELDER PHARMACEUTICALS LTD | Injection | 1 | 87.00 | 46341507.00 | 2.68% | 87.00 | -- |
| 19 | FORMIC 1000/500 MG INJECTION 10 ML | ELDER PHARMACEUTICALS LTD | Injection | 1 | 87.00 | 5396088.00 | 0.31% | 87.00 | -- |
| 20 | EMTRIAXONE SB 1000/500 MG INJECTION 1 | EMBIOTIC LAB | Injection | 1 | 96.56 | 872964.16 | 0.05% | 96.56 | -- |
| 21 | EKCEF S 1000/500 MG INJECTION 5 ML | EUPHORIC PHARMACEUTICALS (P) LTD | Injection | 1 | 100.01 | 1567158.36 | 0.09% | 100.01 | -- |
| 22 | ODICEF S 1000/500 MG INJECTION 1 | GALPHA LABORATORIES LTD | Injection | 1 | 90.67 | 20323045.81 | 1.18% | 90.67 | -- |
| 23 | MILIBACT 1000/500 MG INJECTION 10 ML | GLENMARK PHARMACEUTICALS LTD. | Injection | 1 | 99.28 | 66444132.80 | 3.85% | 99.28 | -- |
| 24 | TERICEF 1000/500 MG INJECTION 1 ML | GOLD LINE | Injection | 1 | 100.57 | 3596886.05 | 0.21% | 100.57 | -- |
| 25 | TERICEF MONO 1000/500 MG INJECTION 1 ML | GOLD LINE | Injection | 1 | 46.40 | 1273448.00 | 0.07% | 46.40 | -- |
| 26 | GRACEF SB 1000/500 MG INJECTION 1 | GRAF LABORATORIES PVT LTD | Injection | 1 | 80.00 | 118863.66 | 0.01% | 80.00 | -- |
| 27 | CESAFE SM 1000/500 MG INJECTION 1 ML | GUJARAT TERCE LABORATORIES LTD | Injection | 1 | 76.19 | 352481.59 | 0.02% | 76.19 | -- |
| 28 | CEFTICHEK 1000/500 MG INJECTION 1 | INDOCO REMEDIES LTD | Injection | 1 | 44.45 | 3537286.55 | 0.20% | 44.45 | -- |
| 29 | KEFTRAGARD 1000/500 MG INJECTION 20 ML | IPCA LABORATORIES PVT LTD. | Injection | 1 | 94.47 | 34844409.27 | 2.02% | 94.47 | -- |
| 30 | CEBACTUM 1000/500 MG INJECTION 1 | LEBEN LABORATORIES PVT.LTD | Injection | 1 | 77.00 | 2926723.36 | 0.17% | 77.00 | -- |
| 31 | TRIXON S 1000/500 MG INJECTION 10 ML | LINCOLN PHARMACEUTICALS LTD | Injection | 1 | 87.62 | 31793763.77 | 1.84% | 87.62 | -- |
| 32 | SUPRAXONE-S 1000/500 MG INJECTION 1 | LUPIN LTD | Injection | 1 | 28.50 | 688532.00 | 0.04% | 28.50 | -- |
| 33 | XONE-CEFF-S 1000/500 MG INJECTION 1 | LUPIN LTD | Injection | 1 | 45.00 | 236637.00 | 0.01% | 45.00 | -- |
| 34 | ACCUZON PLUS 1000/500 MG INJECTION 1 | MACLEODS PHARMACEUTICALS PVT.LTD | Injection | 1 | 89.14 | 41827964.46 | 2.42% | 89.14 | -- |
| 35 | CEFRINE PLUS 1000/500 MG INJECTION 1 | MACLEODS PHARMACEUTICALS PVT.LTD | Injection | 1 | 89.14 | 35373871.90 | 2.05% | 89.14 | -- |
| 36 | MACZONE PLUS 1000/500 MG INJECTION 10 ML | MACLEODS PHARMACEUTICALS PVT.LTD | Injection | 1 | 89.14 | 25926190.72 | 1.50% | 89.14 | -- |
| 37 | MAHACEF-SB 1000/500 MG INJECTION 1 | MANKIND PHARMACEUTICALS LTD. | Injection | 1 | 86.86 | 100223761.38 | 5.81% | 86.86 | -- |
| 38 | CEZOPRIME 1000/500 MG INJECTION 1 | MEDLEY PHARMACEUTICALS | Injection | 1 | 128.76 | 3784256.40 | 0.22% | 128.76 | -- |
| 39 | CEFODIN S 1000/500 MG INJECTION 1 | MERIDIAN MEDICARE LTD. | Injection | 1 | 105.17 | 2814980.22 | 0.16% | 105.17 | -- |
| 40 | GRAMOCEF S 1000/500 MG INJECTION 1 | MICRO LABS LTD | Injection | 1 | 114.96 | 49588069.38 | 2.87% | 114.96 | -- |
| 41 | ZENCEF SB (MODI) 1000/500 MG INJECTION 1 | MODI MUNDI PHARMA PVT LTD | Injection | 1 | 119.55 | 1139979.62 | 0.07% | 119.55 | -- |
| 42 | CEFTRICA S 1000/500 MG INJECTION 2 ML | MOLEKULE (IND)PVT LTD | Injection | 1 | 100.00 | 5681075.40 | 0.33% | 100.00 | -- |
| 43 | EFECTAL S 1000/500 MG INJECTION 1 | NEON LABORATORIES LTD | Injection | 1 | 54.00 | 299766.00 | 0.02% | 54.00 | -- |
| 44 | SACTUM 1000/500 MG INJECTION 1 | PROFIC ORGANICS | Injection | 1 | 109.80 | 4581954.00 | 0.27% | 109.80 | -- |
| 45 | PILCEF SB 1000/500 MG INJECTION 1 | PSYCHOTROPICS INDIA LTD | Injection | 1 | 98.80 | 3845987.60 | 0.22% | 98.80 | -- |
| 46 | OFRAMAX FORTE 1000/500 MG INJECTION 10 ML | RANBAXY LABORATORIES LTD | Injection | 1 | 49.00 | 118875375.00 | 6.89% | 49.00 | -- |
| 47 | EFOCEFT S 1000/500 MG INJECTION 1 | RELIANCE FORMULATION PVT LTD | Injection | 1 | 87.62 | 995800.74 | 0.06% | 87.62 | -- |
| 48 | RECEF S 1000/500 MG INJECTION 1 | S.R.PHARMACEUTICALS | Injection | 1 | 91.20 | 261744.00 | 0.02% | 91.20 | -- |
| 49 | I TAX S 1000/500 MG INJECTION 1 | SANJIVINI BIOTECH PRIVATE LIMITED | Injection | 1 | 91.30 | 364816.77 | 0.02% | 91.30 | -- |
| 50 | XTUM 1000/500 MG INJECTION 10 ML | SHREYA LIFE SCIENCES PVT. LTD | Injection | 1 | 112.78 | 41149796.14 | 2.38% | 112.78 | -- |
| 51 | CEFERA S 1000/500 MG INJECTION 10 ML | SHREYA LIFE SCIENCES PVT. LTD | Injection | 1 | 112.78 | 14864021.34 | 0.86% | 112.78 | -- |
| 52 | ANCEF SB 1000/500 MG INJECTION 1 | SHRINIVAS GUJARAT LABORATORIES PVT LT | Injection | 1 | 87.24 | 1380091.22 | 0.08% | 87.24 | -- |
| 53 | STERCEF S 1000/500 MG INJECTION 1 ML | STERKEM | Injection | 1 | 95.84 | 909818.88 | 0.05% | 95.84 | -- |
| 54 | XL ONE 1000/500 MG INJECTION 5 ML | THEMIS MEDICARE LTD. | Injection | 1 | 93.23 | 26229930.21 | 1.52% | 93.23 | -- |
| 55 | TG CEF S 1000/500 MG INJECTION 10 ML | TRENDS PHARMA PVT. LTD. | Injection | 1 | 73.90 | 203520.60 | 0.01% | 73.90 | -- |
| 56 | TROYAXONE S 1000/500 MG INJECTION 1 | TROIKAA PHARMACEUTICALS LTD | Injection | 1 | 118.10 | 24226089.20 | 1.40% | 118.10 | -- |
| 57 | UNITRAX S 1000/500 MG INJECTION 1 | UNITED BIOTECH (P) LTD | Injection | 1 | 93.20 | 5844973.73 | 0.34% | 93.20 | -- |
| 58 | SULBACTOMAX 1000/500 MG INJECTION 10 ML | VENUS REMEDIES LTD | Injection | 1 | 93.20 | 5557954.87 | 0.32% | 93.20 | -- |
| 59 | CEFTRIMAX 1000/500 MG INJECTION 1 | VHB LIFE SCIENCES INC | Injection | 1 | 95.23 | 23686538.12 | 1.37% | 95.23 | -- |
| 60 | WAVOCEF S 1000/500 MG INJECTION 1 | WAVES BIOTECH PVT. LTD. | Injection | 1 | 104.17 | 980964.85 | 0.06% | 104.17 | -- |
| 61 | POWERCEF XP 1000/500 MG INJECTION 10 ML | WOCKHARDT LTD | Injection | 1 | 99.21 | 50377196.37 | 2.92% | 99.21 | -- |
| 62 | NOSOCEF S 1000/500 MG INJECTION 5 ML | WOCKHARDT LTD | Injection | 1 | 28.00 | 1259314.25 | 0.07% | 28.00 | -- |
| 63 | MONOBACT 1000/500 MG INJECTION 2 ML | ZUVENTUS HEALTHCARE LTD | Injection | 1 | 98.06 | 71976628.36 | 4.17% | 98.06 | -- |
-- |
-- |
-- |
-- |
-- |
-- |
1,726,033,843 | 100.00% | 85.08 | 98.69 |
-- |
-- |
-- |
-- |
-- |
-- |
Maximum | 118.10 | Minimum | 28.00 |
-- |
-- |
-- |
-- |
-- |
|||||
-- |
As per the above there are 22 companies consisting of Market Share of 1% & Above | -- |
|||||||
-- |
Sum of MAT value considered for price calculation | -- |
-- |
16231.97 | (Rs. in Lakhs) | -- |
|||
-- |
Sum of PTR per unit considered for price calculation | -- |
-- |
2382.14 | -- |
-- |
|||
-- |
Number of Packs considered | -- |
-- |
28 | -- |
-- |
-- |
||
-- |
Retail Price | -- |
-- |
85.08 | -- |
-- |
|||
-- |
Add : 16% Retailer Margin | -- |
-- |
13.61 | -- |
-- |
|||
-- |
MRP (without local taxes) | -- |
-- |
98.69 | S.O. No. 842(E) dt. 25.03.2015 | -- |
|||
-- |
% Reduction with compared to Highest Price | -- |
-- |
27.96% | -- |
-- |
|||
Source of Data – Pharma Trac (June, 2014)
| S.No. | Composition of the Product | Company | Dosage Form | Pack size | Price to Retailer (Rs.) | MAT Value | MAT % | Price per tablet | Retail Price with 16 % Margin |
|---|---|---|---|---|---|---|---|---|---|
-- |
Telvilite H Tablet Each uncoated tablet contains Telmisartan 80 mg Hydrochlorthiazide 12.5 mg |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
| 1 | TELPRES H 80/12.5 MG TABLET 10 | ABBOTT HEALTHCARE PVT. LTD | Tablet | 10 | 115.58 | 21991947.82 | 2.65% | 11.56 | -- |
| 2 | TELLZY H 80/12.5 MG TABLET 10 | ALEMBIC LTD | Tablet | 10 | 106.66 | 12972415.84 | 1.56% | 10.67 | -- |
| 3 | TETAN H 80/12.5 MG TABLET 10 | ALEMBIC LTD | Tablet | 10 | 105.90 | 1811313.60 | 0.22% | 10.59 | -- |
| 4 | TELVAS H 80/12.5 MG TABLET 10 | ARISTO PHARMACEUTICALS PVT.LTD | Tablet | 10 | 69.29 | 42187448.33 | 5.08% | 6.93 | -- |
| 5 | TELMISAT-H 80/12.5 MG TABLET 10 | BIOCON LTD | Tablet | 10 | 115.81 | 4287633.63 | 0.52% | 11.58 | -- |
| 6 | CRESAR H 80/12.5 MG TABLET 10 | CIPLA LTD. | Tablet | 10 | 95.24 | 5190960.96 | 0.63% | 9.52 | -- |
| 7 | TELSARTAN H 80/12.5 MG TABLET 10 | DR. REDDYS LABORATORIES LTD | Tablet | 10 | 104.91 | 45804125.64 | 5.52% | 10.49 | -- |
| 8 | TELSARTAN H ACTIV 80/12.5 MG TABLET 30 | DR. REDDYS LABORATORIES LTD | Tablet | 30 | 148.57 | 34566687.15 | 4.16% | 4.95 | -- |
| 9 | E TEL H 80/12.5 MG TABLET 10 | EMCURE PHARMACEUTICALS LTD | Tablet | 10 | 37.68 | 860008.32 | 0.10% | 3.77 | -- |
| 10 | ERITEL H 80/12.5 MG TABLET 10 | ERIS LIFE SCIENCES PVT LTD | Tablet | 10 | 112.76 | 44219285.04 | 5.33% | 11.28 | -- |
| 11 | TELMA H 80/12.5 MG TABLET 15 | GLENMARK PHARMACEUTICALS LTD. | Tablet | 15 | 187.66 | 325583531.90 | 39.22% | 12.51 | -- |
| 12 | TELMINORM H 80/12.5 MG TABLET 10 | IPCA LABORATORIES PVT LTD. | Tablet | 10 | 97.52 | 5020571.52 | 0.60% | 9.75 | -- |
| 13 | TELISTA-H 80/12.5 MG TABLET 15 | LUPIN LTD | Tablet | 15 | 177.47 | 22867896.85 | 2.75% | 11.83 | -- |
| 14 | TELMIKIND H 80/12.5 MG TABLET 10 | MANKIND PHARMACEUTICALS LTD. | Tablet | 10 | 44.80 | 94318097.16 | 11.36% | 4.48 | -- |
| 15 | TELMED H 80/12.5 MG TABLET 10 | MEDLEY PHARMACEUTICALS | Tablet | 10 | 90.66 | 2041753.86 | 0.25% | 9.07 | -- |
| 16 | ARBITEL H 80/12.5 MG TABLET 10 | MICRO LABS LTD | Tablet | 10 | 115.49 | 13798315.80 | 1.66% | 11.55 | -- |
| 17 | AXETEN H 80/12.5 MG TABLET 10 | ORGANON (INDIA) LTD | Tablet | 10 | 107.43 | 2025055.50 | 0.24% | 10.74 | -- |
| 18 | TARGIT H 80/12.5 MG TABLET 10 | PFIZER LTD | Tablet | 10 | 88.54 | 2997964.40 | 0.36% | 8.85 | -- |
| 19 | TELEACT-D 80/12.5 MG TABLET 10 | RANBAXY LABORATORIES LTD | Tablet | 10 | 124.95 | 7089590.18 | 0.85% | 12.50 | -- |
| 20 | TELSITE H 80/12.5 MG TABLET 10 | SANOFI INDIA LTD. | Tablet | 10 | 106.66 | 810935.98 | 0.10% | 10.67 | -- |
| 21 | NEWTEL H 80/12.5 MG TABLET 10 | SYSTOPIC LABORATORIES LTD-MEM | Tablet | 10 | 53.51 | 2959798.63 | 0.36% | 5.35 | -- |
| 22 | TELDAY H 80/12.5 MG TABLET 10 | TORRENT PHARMACEUTICALS LTD. | Tablet | 10 | 107.43 | 29281443.09 | 3.53% | 10.74 | -- |
| 23 | TELMIKAA H 80/12.5 MG TABLET 10 | TROIKAA PHARMACEUTICALS LTD | Tablet | 10 | 115.81 | 984748.85 | 0.12% | 11.58 | -- |
| 24 | TELSAR-H 80/12.5 MG TABLET 10 | UNICHEM LABORATORIES LTD | Tablet | 10 | 109.71 | 33218322.93 | 4.00% | 10.97 | -- |
| 25 | TAZLOC H 80/12.5 MG TABLET 10 | USV LTD | Tablet | 10 | 113.90 | 63941150.18 | 7.70% | 11.39 | -- |
| 26 | T-MART H 80/12.5 MG TABLET 10 | WALLACE PHARMACEUTICALS LTD. | Tablet | 10 | 95.24 | 959963.37 | 0.12% | 9.52 | -- |
| 27 | TEMAX H 80/12.5 MG TABLET 14 | WOCKHARDT LTD | Tablet | 14 | 110.48 | 1164459.20 | 0.14% | 7.89 | -- |
| 28 | INDITEL H 80/12.5 MG TABLET 10 | ZYDUS CADILA | Tablet | 10 | 84.39 | 7169858.79 | 0.86% | 8.44 | -- |
-- |
-- |
-- |
-- |
-- |
-- |
830,125,285 | 100.00% | 10.00 | 11.60 |
-- |
-- |
-- |
-- |
-- |
-- |
Maximum | 12.51 | Minimum | 4.48 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
||
-- |
As per the above there are 12 companies consisting of Market Share of 1% & Above | -- |
-- |
-- |
-- |
||||
-- |
Sum of MAT value considered for price calculation | -- |
-- |
7865.62 | (Rs. in Lakhs) | -- |
|||
-- |
Sum of PTR per unit considered for price calculation | -- |
-- |
139.94 | -- |
-- |
|||
-- |
Number of Packs considered | -- |
-- |
14 | -- |
-- |
|||
-- |
Retail Price | -- |
-- |
10.00 | -- |
-- |
|||
-- |
Add : 16% Retailer Margin | -- |
-- |
1.60 | -- |
-- |
|||
-- |
MRP (without local taxes) | -- |
-- |
11.60 | S.O. No. 843(E) dt. 25.03.2015 | -- |
|||
-- |
% Reduction with compared to Highest Price | -- |
-- |
20.06% | -- |
-- |
|||
Source of Data-IMS-Health Jan, 2014
| S.No. | Composition of the formulation | Company | Dosage Form | Pack Size | MAT Units | Price to Retailer (Rs.) | MAT Value | MAT % | Price per Tablet | Ceiling Price with 16 % Margin |
|---|---|---|---|---|---|---|---|---|---|---|
-- |
Paracetamol Tablet 650 mg | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
| 1 | MALIDENS TABS 650 MG x 10 | ABBOTT HEALTHCARE | Tablet | 10 | 646,988 | 16.00 | 9,528,287 | 0.84% | 1.60 | -- |
| 2 | DOLIPRANE TABS 650 MGx10 | ABBOTT HEALTHCARE | Tablet | 10 | 150,048 | 11.05 | 1,658,025 | 0.15% | 1.11 | -- |
| 3 | ARDEN TAB UNCOATED 650 MG x 10 | ADONIS | Tablet | 10 | 361,899 | 11.05 | 3,998,994 | 0.35% | 1.11 | -- |
| 4 | SUMOL TABS ER 650 MG x 10 | ALKEM | Tablet | 10 | 590,669 | 15.40 | 8,498,135 | 0.75% | 1.54 | -- |
| 5 | PYRAKEM TAB UNCOATED 650 MG x 10 | ALKEM | Tablet | 10 | 123,666 | 2.86 | 353,682 | 0.03% | 0.29 | -- |
| 6 | P.U.C TABS 650 MG x 10 | ALKEM | Tablet | 10 | 34,766 | 10.13 | 334,063 | 0.03% | 1.01 | -- |
| 7 | PYREMOL 650 MG X 10 | ALEMBIC | Tablet | 10 | 323,504 | 10.40 | 3,364,444 | 0.30% | 1.04 | -- |
| 8 | NOVA TAB UNCOATED 650 MG x 10 | AMAZON DRUG | Tablet | 10 | 33,125 | 14.72 | 487,602 | 0.04% | 1.47 | -- |
| 9 | PARACETAMOL APEX TABS 650 MG x 10 | APEX | Tablet | 10 | 4,722,986 | 14.63 | ######## | 5.99% | 1.46 | -- |
| 10 | PRACEMO TAB UNCOATED 650 MG x 10 | ASHOK PHARMA | Tablet | 10 | 14,376 | 10.80 | 155,261 | 0.01% | 1.08 | -- |
| 11 | CENTAMOL TAB UNCOATED 650 MG x 10 | CENTAUR | Tablet | 10 | 118,204 | 12.22 | 1,504,502 | 0.13% | 1.22 | -- |
| 12 | PARACIP TABS 650 MG x 10 | CIPLA | Tablet | 10 | 3,042,759 | 4.03 | ######## | 1.08% | 0.40 | -- |
| 13 | COPAR TAB UNCOATED 650 MG x 10 | COMED CHEMICALS | Tablet | 10 | 42,989 | 16.35 | 702,870 | 0.06% | 1.64 | -- |
| 14 | NU-650 FILM C.TABS 650 MG x 15 | DELVIN FORMULATION | Tablet | 15 | 55,521 | 30.03 | 1,756,932 | 0.15% | 2.00 | -- |
| 15 | PYRIGESIC TAB UNCOATED 650 MG x 10 | EAST INDIA | Tablet | 10 | 3,210,285 | 11.93 | ######## | 3.33% | 1.19 | -- |
| 16 | FEPAMOL TAB UNCOATED 650 MG x 10 | EAST WEST PHARMA | Tablet | 10 | 16,529 | 12.55 | 207,437 | 0.02% | 1.26 | -- |
| 17 | FLUMOL TABS DISPERS 650 MG x 10 | ELDER PHARMA | Tablet | 10 | 19,005 | 4.63 | 87,992 | 0.01% | 0.46 | -- |
| 18 | ADMOL TABS 650 MG x 10 | ETHICARE PHARMA | Tablet | 10 | 162,832 | 14.28 | 2,210,931 | 0.19% | 1.43 | -- |
| 19 | ACTON TAB UNCOATED 650 MG x 10 | FRANKLIN LABS | Tablet | 10 | 8,091 | 13.08 | 105,831 | 0.01% | 1.31 | -- |
| 20 | ALGINA TAB UNCOATED 650 MG x 10 | GENO | Tablet | 10 | 252,609 | 5.04 | 1,273,158 | 0.11% | 0.50 | -- |
| 21 | CALPOL TAB 650 MG x 10 | GLAXOSMITHKLINE | Tablet | 10 | 6,021,771 | 20.21 | ######## | 10.69% | 2.02 | -- |
| 22 | CROCIN TAB UNCOATED 650 MG x 10 | GSK CONSUMER HC | Tablet | 10 | 119,323 | 11.17 | 1,332,837 | 0.12% | 1.12 | -- |
| 23 | TYNOL TABS 650 MG x 10 | GUJARAT TERCE | Tablet | 10 | 31,935 | 6.41 | 204,703 | 0.02% | 0.64 | -- |
| 24 | LANOL FIL.C.TAB.ER 650 MG x 10 | HETERO HEALTHCARE | Tablet | 10 | 3,057,051 | 15.16 | ######## | 4.07% | 1.52 | -- |
| 25 | LANOL FIL.C.TAB.ER 650 MG x 6 | HETERO HEALTHCARE | Tablet | 6 | 32,527 | 13.14 | 427,405 | 0.04% | 2.19 | -- |
| 26 | PMO TAB UNCOATED 650 MG x 10 | INDCHEMIE | Tablet | 10 | 12,378 | 16.94 | 215,755 | 0.02% | 1.69 | -- |
| 27 | FEBREX TAB UNCOATED 650 MG x 10 | INDOCO | Tablet | 10 | 569,267 | 12.25 | 7,031,212 | 0.62% | 1.23 | -- |
| 28 | FEBREX TAB UNCOA.ER 650 MG x 10 | INDOCO | Tablet | 10 | 51,283 | 17.18 | 881,039 | 0.08% | 1.72 | -- |
| 29 | PCM TABS 650 MG x 10 | INTAS | Tablet | 10 | 158,750 | 8.48 | 1,346,205 | 0.12% | 0.85 | -- |
| 30 | CROPARA TAB UNCOATED 650 MG x 10 | INVIDA INDIA | Tablet | 10 | 8,234 | 11.45 | 94,280 | 0.01% | 1.15 | -- |
| 31 | PACIMOL TAB UNCOATED 650 MG x 10 | IPCA LABS | Tablet | 10 | 1,346,447 | 14.78 | ######## | 1.75% | 1.48 | -- |
| 32 | KELVIN TAB UNCOATED 650 MG x 10 | LEBEN LABS | Tablet | 10 | 53,403 | 10.63 | 567,672 | 0.05% | 1.06 | -- |
| 33 | TEMPTAL CAPLETS 650 MG x 10 | LI TAKA PHARMA | Tablet | 10 | 173,047 | 12.31 | 2,108,899 | 0.19% | 1.23 | -- |
| 34 | ULTRAPYRIN TABS FORT 650 MG x 10 | LINCOLN PHARMA | Tablet | 10 | 9,654 | 7.05 | 68,061 | 0.01% | 0.71 | -- |
| 35 | LUPIPARA TABS 650 MG x 10 | LUPIN LABS | Tablet | 10 | 180,900 | 3.40 | 615,051 | 0.05% | 0.34 | -- |
| 36 | MACFAST TAB UNCOATED 650 MG x 10 | MACLEODS PHARMA | Tablet | 10 | 825,031 | 14.04 | ######## | 1.04% | 1.40 | -- |
| 37 | T-98 TABS 650 MG x 10 | MANKIND | Tablet | 10 | 26,786 | 9.52 | 256,765 | 0.02% | 0.95 | -- |
| 38 | MEDOMOL TABS 650 MG x 10 | MEDO PHARMA | Tablet | 10 | 1,253,977 | 11.94 | ######## | 1.29% | 1.19 | -- |
| 39 | DOLO TAB UNCOATED 650 MG x 15 | MICRO LABS | Tablet | 15 | 25,513,765 | 25.79 | ######## | 57.81% | 1.72 | -- |
| 40 | MEPROCIN TAB UNCOATED 650 MG x 10 | MPI | Tablet | 10 | 24,846 | 11.85 | 294,424 | 0.03% | 1.19 | -- |
| 41 | PYREX TABS 650 MG x 10 | NOEL PHARMA | Tablet | 10 | 28,661 | 8.75 | 250,782 | 0.02% | 0.88 | -- |
| 42 | PAAR TABS DISPERS 650 MG x 10 | OMEGA REMEDIES | Tablet | 10 | 10,533 | 8.21 | 86,477 | 0.01% | 0.82 | -- |
| 43 | PEDMOL TAB UNCOATED 650 MG x 10 | PHARM PRODUCTS | Tablet | 10 | 24,657 | 9.58 | 236,214 | 0.02% | 0.96 | -- |
| 44 | WELSET TABS 650 MG x 10 | RANBAXY | Tablet | 10 | 1,571,707 | 8.00 | ######## | 1.10% | 0.80 | -- |
| 45 | DOLIZA FIL.C.TAB.ER 650 MG x 10 | RANBAXY | Tablet | 10 | 277,615 | 16.00 | 4,342,837 | 0.38% | 1.60 | -- |
| 46 | PAARMOL TABS 650 MG x 10 | RANBAXY | Tablet | 10 | 144,336 | 11.38 | 1,642,546 | 0.14% | 1.14 | -- |
| 47 | WELSET TABS 650 MG x 6 | RANBAXY | Tablet | 6 | 45,463 | 6.12 | 278,228 | 0.02% | 1.02 | -- |
| 48 | VOLINI DUO TABS 650 MG x 10 | RANBAXY GLOBAL CHC | Tablet | 10 | 177,376 | 15.31 | 2,715,626 | 0.24% | 1.53 | -- |
| 49 | ACETO TAB UNCOATED 650 MG x 10 | SHIELD HEALTHCARE | Tablet | 10 | 133,145 | 15.24 | 1,935,640 | 0.17% | 1.52 | -- |
| 50 | FEBRINIL TAB UNCOATED 650 MG x 10 | SVIZERA HEALTHCARE | Tablet | 10 | 330,633 | 10.59 | 3,455,088 | 0.30% | 1.06 | -- |
| 51 | MEDIMOL TABS DISPERS 650 MG x 10 | SYNCHEM LABS | Tablet | 10 | 22,285 | 9.38 | 209,034 | 0.02% | 0.94 | -- |
| 52 | SYSDOL TAB UNCOATED 650 MG x 10 | SYSMED LAB | Tablet | 10 | 409,569 | 9.23 | 3,916,594 | 0.34% | 0.92 | -- |
| 53 | PYRIT TAB UNCOATED 650 MG x 15 | TAS MED | Tablet | 15 | 34,362 | 22.08 | 792,585 | 0.07% | 1.47 | -- |
| 54 | METAPLUS TABS 650 MG x 10 | THEMIS PHARMA | Tablet | 10 | 99,462 | 12.45 | 1,177,252 | 0.10% | 1.25 | -- |
| 55 | XYKAA RAPID TABS 650 MG x 10 | TROIKAA PHARMA | Tablet | 100 | 67,052 | 177.69 | ######## | 1.05% | 1.78 | -- |
| 56 | AMOL TAB UNCOATED 650 MG x 10 | UNICHEM | Tablet | 10 | 36,184 | 4.24 | 143,545 | 0.01% | 0.42 | -- |
| 57 | TALMIN TABS 650 MG x 10 | UNIMARK | Tablet | 10 | 10,199 | 13.63 | 139,012 | 0.01% | 1.36 | -- |
| 58 | PMSON TAB UNCOATED 650 MG x 10 | UNISON PHARMA | Tablet | 10 | 83,690 | 7.70 | 644,406 | 0.06% | 0.77 | -- |
| 59 | PMSON TABS ER 650 MG x 10 | UNISON PHARMA | Tablet | 10 | 61,064 | 9.24 | 564,229 | 0.05% | 0.92 | -- |
| 60 | TYFY TABS 650 MG x 10 | VANGUARD | Tablet | 10 | 228,751 | 12.05 | 2,756,451 | 0.24% | 1.21 | -- |
| 61 | FEPANIL TAB UNCOATED 650 MG x 10 | VERITAZ HEALTHCARE | Tablet | 10 | 2,662,894 | 13.48 | ######## | 2.73% | 1.35 | -- |
| 62 | FEPANIL CAPLETS 650 MG x 10 | VERITAZ HEALTHCARE | Tablet | 10 | 677,642 | 13.48 | 8,484,667 | 0.75% | 1.35 | -- |
| 63 | OPARA TAB UNCOATED 650 MG x 10 | WALLACE | Tablet | 10 | 76,726 | 13.55 | 1,020,969 | 0.09% | 1.36 | -- |
| 64 | MERIMOL TABS DISPERS 650 MG x 10 | WOCKHARDT | Tablet | 10 | 341,911 | 13.95 | 4,769,648 | 0.42% | 1.40 | -- |
| 65 | FEVRIDOL TABS ER 650 MG x 10 | ZUVENTUS PHARMA | Tablet | 10 | 20,038 | 17.79 | 356,476 | 0.03% | 1.78 | -- |
| 66 | BIOCETAMOL TABS OVAL 650 MG x 10 | ZYDUS BIOCHEM | Tablet | 10 | 21,588 | 4.09 | 88,294 | 0.01% | 0.41 | -- |
| 67 | CETA TAB UNCOATED 650 MG x 10 | #N/A | Tablet | 10 | 10,711 | 13.71 | 151,273 | 0.01% | 1.37 | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
######## | ###### | 1.40 | 1.62 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
maximum | 2.19 | Minimum | 0.40 |
-- |
As per the above there are 12 companies consisting of Market Share of 1% & Above | -- |
-- |
-- |
-- |
-- |
-- |
|||
-- |
Sum of MAT value considered for price calculation | -- |
-- |
-- |
10641.88 | (Rs. in Lakhs) | -- |
|||
-- |
Sum of PTR per unit considered for price calculation | -- |
-- |
-- |
25.14 | -- |
-- |
|||
-- |
Number of Packs considered | -- |
-- |
-- |
18 | -- |
-- |
|||
-- |
Ceiling Price | -- |
-- |
-- |
1.40 | -- |
-- |
|||
-- |
Add : 16% Retailer Margin | -- |
-- |
-- |
0.22 | -- |
-- |
|||
-- |
MRP (without local taxes) | -- |
-- |
-- |
1.62 | S.O. No. 847(E) dt. 25.03.2015 | -- |
|||
-- |
% Reduction with compared to Highest Price | -- |
-- |
-- |
36.07% | -- |
-- |
|||
Source of Data-IMS/Companies ( feb,
| S.No. | Composition of the Product | Company | Dosage Form | Pack size | Price to Retailer (Rs.) | MAT Value | MAT % | Price per ml | Retail Price with 16 % Margin |
|---|---|---|---|---|---|---|---|---|---|
-- |
Trusten O Dry Syrup Each 5 ml Reconstituted suspension contains: Cefixime (as trihydrate) eq. to Cefixime (Anhydrous) 50 mg |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
| 1 | OMNATAX-O SYRUP DRY 50 MG 30 ML x 1 (/5ML) | ABBOTT HEALTHCARE | Dry Syrup | 30 | 38.89 | 13,069,130 | 1.55% | 1.30 | -- |
| 2 | ZIMNIC SYRUP DRY 50 MG 30 ML x 1 (/5ML) | ABBOTT HEALTHCARE | Dry Syrup | 30 | 25.90 | 10,356,376 | 1.22% | 0.86 | -- |
| 3 | CEFI SYRUP DRY 50 MG 30 ML x 1 (/5ML) | ABBOTT HEALTHCARE | Dry Syrup | 30 | 26.67 | 7,011,199 | 0.83% | 0.89 | -- |
| 4 | ZIMNIC SUSP REDIMIX 50 MG 30 ML x 1 (/5ML) | ABBOTT HEALTHCARE | Dry Syrup | 30 | 41.90 | 1,761,644 | 0.21% | 1.40 | -- |
| 5 | CEFI SUSP DRY 50 MG 30 ML x 1 | ABBOTT HEALTHCARE | Dry Syrup | 30 | 28.27 | 567,096 | 0.07% | 0.94 | -- |
| 6 | SAFEXIM SYRUP DRY 50 MG 30 ML x 1 (/5ML) | ABBOTT HEALTHCARE | Dry Syrup | 30 | 14.00 | 441,915 | 0.05% | 0.47 | -- |
| 7 | ACROTEX SYRUP DRY 50 MG 30 ML x 1 (/5ML) | ACRON | Dry Syrup | 30 | 89.36 | 103,747 | 0.01% | 2.98 | -- |
| 8 | ZEEFIX SYRUP DRY 50 MG 30 ML x 1 (/5ML) | AGIO PHARMA | Dry Syrup | 30 | 26.67 | 267,073 | 0.03% | 0.89 | -- |
| 9 | PANCEF-O SYRUP DRY 50 MG 30 ML x 1 (/5ML) | AGLOWMED | Dry Syrup | 30 | 35.01 | 8,966,906 | 1.06% | 1.17 | -- |
| 10 | ZOFIX SUSP DRY PD. 50 MG 30 ML x 1 (/5ML) | ALEMBIC | Dry Syrup | 30 | 34.59 | 6,218,889 | 0.74% | 1.15 | -- |
| 11 | CIFADIN SYRUP DRY 50 MG 30 ML x 1 (/5ML) | ALEMBIC | Dry Syrup | 30 | 43.35 | 3,107,778 | 0.37% | 1.45 | -- |
| 12 | TAXIM-O SYRUP DRY 50 MG 30 ML x 1 (/5ML) | ALKEM | Dry Syrup | 30 | 45.43 | 331,949,005 | 39.24% | 1.51 | -- |
| 13 | PEDIXIM SYRUP DRY 50 MG 30 ML x 1 (/5ML) | BIOLOGICAL E | Dry Syrup | 30 | 45.86 | 926,463 | 0.11% | 1.53 | -- |
| 14 | GEOSEF SYRUP DRY 50 MG 30 ML x 1 (/5ML) | BLISS | Dry Syrup | 30 | 36.79 | 460,610 | 0.05% | 1.23 | -- |
| 15 | EXTACEF SYRUP DRY 50 MG 30 ML x 1 (/5ML) | BLUE CROSS | Dry Syrup | 30 | 30.48 | 22,200,000 | 2.62% | 1.02 | -- |
| 16 | BRUFIX SYRUP DRY 50 MG 30 ML x 1 (/5ML) | BRAWN | Dry Syrup | 30 | 38.38 | 69,698 | 0.01% | 1.28 | -- |
| 17 | TRAXOL-O SYRUP DRY 50 MG 30 ML x 1 (/5ML) | CACHET | Dry Syrup | 30 | 35.99 | 8,955,221 | 1.06% | 1.20 | -- |
| 18 | CEFICAD-O SYRUP DRY 50 MG 30 ML x 1 (/5ML) | CADILA PHARMA | Dry Syrup | 30 | 31.17 | 668,534 | 0.08% | 1.04 | -- |
| 19 | ORITAXIM-O SUSP DRY 50 MG 30 ML x 1 (/5ML) | CADILA PHARMA | Dry Syrup | 30 | 21.00 | 156,115 | 0.02% | 0.70 | -- |
| 20 | OMNIX SYRUP DRY 50 MG 30 ML x 1 (/5ML) | CIPLA | Dry Syrup | 30 | 31.57 | 40,999,137 | 4.85% | 1.05 | -- |
| 21 | ZIPRAX SUSP DRY 50 MG 30 ML x 1 (/5ML) | CIPLA | Dry Syrup | 30 | 31.57 | 24,669,237 | 2.92% | 1.05 | -- |
| 22 | CEFIX SUSP DRY 50 MG 30 ML x 1 (/5ML) | CIPLA | Dry Syrup | 30 | 28.20 | 3,785,853 | 0.45% | 0.94 | -- |
| 23 | FIXICOM SUSP REDIMIX 50 MG 30 ML x 1 (/5ML) | COMMON WEALTH | Dry Syrup | 30 | 42.51 | 44,805 | 0.01% | 1.42 | -- |
| 24 | XECUTE SYRUP 50 MG 30 ML x 1 (/5ML) | CORONA REMEDIES | Dry Syrup | 30 | 29.71 | 913,050 | 0.11% | 0.99 | -- |
| 25 | REDICATE SYRUP DRY 50 MG 30 ML x 1 (/5ML) | DR REDDYS LABS | Dry Syrup | 30 | 32.38 | 4,503,734 | 0.53% | 1.08 | -- |
| 26 | ELFI SYRUP DRY 50 MG 30 ML x 1 (/5ML) | ELDER PHARMA | Dry Syrup | 30 | 30.41 | 1,034,699 | 0.12% | 1.01 | -- |
| 27 | ZOFTAX-O SYRUP DRY 50 MG 30 ML x 1 (/5ML) | ELDER PHARMA | Dry Syrup | 30 | 49.05 | 362,676 | 0.04% | 1.64 | -- |
| 28 | ZIFI SYRUP DRY 50 MG 30 ML x 1 (/5ML) | FDC | Dry Syrup | 30 | 34.29 | 138,461,205 | 16.37% | 1.14 | -- |
| 29 | ZIFI SUSP REDIMIX 50 MG 30 ML x 1 (/5ML) | FDC | Dry Syrup | 30 | 42.51 | 12,215,337 | 1.44% | 1.42 | -- |
| 30 | ACEF SYRUP DRY 50 MG 30 ML x 1 (/5ML) | FRANKLIN LABS | Dry Syrup | 30 | 30.93 | 210,633 | 0.02% | 1.03 | -- |
| 31 | ODICEF-O SUSP DRY 50 MG 30 ML x 1 (/5ML) | GALPHA LABS | Dry Syrup | 30 | 32.54 | 10,671,581 | 1.26% | 1.08 | -- |
| 32 | CEFSPAN SYRUP DRY 50 MG 30 ML x 1 (/5ML) | GLAXOSMITHKLINE | Dry Syrup | 30 | 34.29 | 9,407,260 | 1.11% | 1.14 | -- |
| 33 | MILIXIM SUSP DRY 50 MG 30 ML x 1 | GLENMARK PHARMA | Dry Syrup | 30 | 31.95 | 7,955,000 | 0.94% | 1.07 | -- |
| 34 | G-XIME SYRUP DRY 50 MG 30 ML x 1 (/5ML) | GRAF LABS | Dry Syrup | 30 | 35.15 | 89,070 | 0.01% | 1.17 | -- |
| 35 | ALMOCEF SYRUP DRY 50 MG 30 ML x 1 (/5ML) | GUJARAT TERCE | Dry Syrup | 30 | 38.15 | 935,057 | 0.11% | 1.27 | -- |
| 36 | HIFEN SYRUP DRY 50 MG 30 ML x 1 (/5ML) | HETERO HEALTHCARE | Dry Syrup | 30 | 26.66 | 18,738,361 | 2.22% | 0.89 | -- |
| 37 | HIFEN SUSP REDIMIX 50 MG 30 ML x 1 (PAED) | HETERO HEALTHCARE | Dry Syrup | 30 | 37.70 | 1,630,750 | 0.19% | 1.26 | -- |
| 38 | IATROCEF SYRUP DRY 50 MG 30 ML x 1 (/5ML) | IATROS PHARMA | Dry Syrup | 30 | 26.16 | 213,491 | 0.03% | 0.87 | -- |
| 39 | VCEF-O SUSP 50 MG 30 ML x 1 (/5ML) | INDOCO | Dry Syrup | 30 | 27.09 | 1,498,999 | 0.18% | 0.90 | -- |
| 40 | FEVORIT SUSP DRY 50 MG 30 ML x 1 (/5ML) | INDOCO | Dry Syrup | 30 | 29.71 | 1,371,802 | 0.16% | 0.99 | -- |
| 41 | CEFINTAS SUSP DRY 50 MG 30 ML x 1 (/5ML) | INTAS | Dry Syrup | 30 | 55.60 | 464,149 | 0.05% | 1.85 | -- |
| 42 | CEFINTA SUSP DRY 50 MG 30 ML x 1 (/5ML) | INTAS | Dry Syrup | 30 | 22.02 | 62,691 | 0.01% | 0.73 | -- |
| 43 | VERIXIME SYRUP DRY 50 MG 30 ML x 1 (/5ML) | KARNATAKA ANTIBIOT | Dry Syrup | 30 | 30.80 | 2,787,895 | 0.33% | 1.03 | -- |
| 44 | TOX-O SUSP DRY ORG 50 MG 30 ML x 1 (/5ML) | LABORATE PHARMA | Dry Syrup | 30 | 48.23 | 267,387 | 0.03% | 1.61 | -- |
| 45 | ZEFIX SUSP DRY 50 MG 30 ML x 1 (/5ML) | LINCOLN PHARMA | Dry Syrup | 30 | 47.42 | 347,826 | 0.04% | 1.58 | -- |
| 46 | LUPICEF SYRUP DRY 50 MG 30 ML x 1 (/5ML) | LUPIN LABS | Dry Syrup | 30 | 17.44 | 147,282 | 0.02% | 0.58 | -- |
| 47 | CEFOLAC SUSP 50 MG 30 ML x 1 (/5ML) | MACLEODS PHARMA | Dry Syrup | 30 | 34.30 | 30,277,884 | 3.58% | 1.14 | -- |
| 48 | ACUFIX SUSP DRY 50 MG 30 ML x 1 (/5ML) | MACLEODS PHARMA | Dry Syrup | 30 | 34.03 | 2,713,683 | 0.32% | 1.13 | -- |
| 49 | BRUTACEF SYRUP DRY 50 MG 30 ML x 1 (/5ML) | MANKIND | Dry Syrup | 30 | 25.90 | 8,900,000 | 1.05% | 0.86 | -- |
| 50 | CEFO SUSP PAED 50 MG 30 ML x 1 (/5ML) | MEDLEY PHARMA | Dry Syrup | 30 | 30.03 | 2,164,325 | 0.26% | 1.00 | -- |
| 51 | CEFX-O SYRUP DRY 50 MG 30 ML x 1 (/5ML) | MEDLEY PHARMA | Dry Syrup | 30 | 19.40 | 96,263 | 0.01% | 0.65 | -- |
| 52 | RITE-O-CEF SYRUP DRY 50 MG 30 ML x 1 (/5ML) | MICRO LABS | Dry Syrup | 30 | 38.05 | 7,320,934 | 0.87% | 1.27 | -- |
| 53 | GRAMOCEF-O SUSP DRY 50 MG 30 ML x 1 (/5ML) | MICRO LABS | Dry Syrup | 30 | 38.05 | 6,323,380 | 0.75% | 1.27 | -- |
| 54 | ALCEF-O SYRUP DRY 50 MG 30 ML x 1 (/5ML) | MICRO LABS | Dry Syrup | 30 | 47.42 | 669,618 | 0.08% | 1.58 | -- |
| 55 | DP SYRUP DRY 50 MG 30 ML x 1 (/5ML) | NOEL PHARMA | Dry Syrup | 30 | 36.57 | 736,699 | 0.09% | 1.22 | -- |
| 56 | ZAFIL SYRUP DRY 50 MG 30 ML x 1 (/5ML) | ORCHID CHEM&PHARMA | Dry Syrup | 30 | 24.39 | 168,778 | 0.02% | 0.81 | -- |
| 57 | JETEX SUSP 50 MG 30 ML x 1 (/5ML) | PFIZER | Dry Syrup | 30 | 29.52 | 651,771 | 0.08% | 0.98 | -- |
| 58 | XIPIL SYRUP DRY 50 MG 30 ML x 1 (/5ML) | PSYCHOTROPICS | Dry Syrup | 30 | 28.61 | 118,960 | 0.01% | 0.95 | -- |
| 59 | NOVAFEX SYRUP DRY 50 MG 30 ML x 1 (/5ML) | RADICURA PHARMA | Dry Syrup | 30 | 49.05 | 203,558 | 0.02% | 1.64 | -- |
| 60 | SKIFI SUSP DRY PD. 50 MG 30 ML x 1 (/5ML) | RANBAXY | Dry Syrup | 30 | 26.66 | 499,502 | 0.06% | 0.89 | -- |
| 61 | CEDRO-CF SUSP DRY 50 MG 30 ML x 1 (/5ML) | REKVINA | Dry Syrup | 30 | 36.79 | 491,220 | 0.06% | 1.23 | -- |
| 62 | FOTAZ-O SYRUP DRY 50 MG 30 ML x 1 (/5ML) | RPG LIFE SCIENCES | Dry Syrup | 30 | 15.40 | 159,406 | 0.02% | 0.51 | -- |
| 63 | SECEF SUSP DRY 50 MG 30 ML x 1 (/5ML) | SANDOZ | Dry Syrup | 30 | 38.02 | 2,565,105 | 0.30% | 1.27 | -- |
| 64 | CLAFORAN-O SYRUP DRY 50 MG 30 ML x 1 (/5ML) | SANOFI AVENTIS | Dry Syrup | 30 | 44.57 | 2,461,907 | 0.29% | 1.49 | -- |
| 65 | SI-FIXIM SYRUP DRY 50 MG 30 ML x 1 (/5ML) | SVIZERA HEALTHCARE | Dry Syrup | 30 | 33.52 | 3,906,915 | 0.46% | 1.12 | -- |
| 66 | TOPCEF SUSP INSTA 50 MG 30 ML x 1 (/5ML) | TORRENT PHARMA | Dry Syrup | 30 | 38.85 | 17,263,978 | 2.04% | 1.30 | -- |
| 67 | FIXX SUSP DRY 50 MG 30 ML x 1 (/5ML) | UNICHEM | Dry Syrup | 30 | 29.64 | 6,157,484 | 0.73% | 0.99 | -- |
| 68 | DELBI SUSP PAED 50 MG 30 ML x 1 (/5ML) | VERITAZ HEALTHCARE | Dry Syrup | 30 | 31.57 | 3,958,148 | 0.47% | 1.05 | -- |
| 69 | O-POWERCEFF SYRUP DRY 50 MG 30 ML x 1 (/5ML) | WOCKHARDT | Dry Syrup | 30 | 22.50 | 4,912,146 | 0.58% | 0.75 | -- |
| 70 | CEFIWOK SUSP REDIMIX 50 MG 30 ML x 1 (/5ML) | WOCKHARDT | Dry Syrup | 30 | 36.15 | 3,985,683 | 0.47% | 1.21 | -- |
| 71 | C-TAX-O SYRUP DRY 50 MG 30 ML x 1 (/5ML) | ZUVENTUS PHARMA | Dry Syrup | 30 | 40.92 | 11,862,294 | 1.40% | 1.36 | -- |
| 72 | BIOTAX-O SYRUP DRY 50 MG 30 ML x 1 (/5ML) | ZYDUS BIOCHEM | Dry Syrup | 30 | 38.43 | 10,309,125 | 1.22% | 1.28 | -- |
| 73 | RAXIM-O SYRUP DRY 50 MG 30 ML x 1 | ZYDUS CADILA | Dry Syrup | 30 | 68.40 | 12,440,658 | 1.47% | 2.28 | -- |
| 74 | FEXIM-O SUSP 50 MG 30 ML x 1 (/5ML) | ZYDUS CADILA | Dry Syrup | 30 | 57.23 | 3,513,405 | 0.42% | 1.91 | -- |
-- |
-- |
-- |
-- |
845,879,195 | ###### | 1.20 | 1.39 | ||
-- |
-- |
-- |
-- |
-- |
Maximum | 2.28 | Minimum | 0.47 | |
-- |
-- |
-- |
-- |
-- |
-- |
||||
-- |
As per the above there are 18 companies consisting of Market Share of 1% & Above | -- |
-- |
-- |
-- |
||||
-- |
Sum of MAT value considered for price calculation | -- |
-- |
7956.77 | (Rs. in Lakhs) | -- |
|||
-- |
Sum of PTR per unit considered for price calculation | -- |
-- |
40.67 | -- |
-- |
|||
-- |
Number of Packs considered | -- |
-- |
34 | -- |
-- |
-- |
||
-- |
Retail Price | -- |
-- |
1.20 | -- |
-- |
|||
-- |
Add : 16% Retailer Margin | -- |
-- |
0.19 | -- |
-- |
|||
-- |
MRP (without local taxes) | -- |
-- |
1.39 | S.O. No. 846(E) dt. 25.03.2015 | -- |
|||
-- |
% Reduction with compared to Highest Price | -- |
-- |
47.37% | -- |
-- |
|||
Data Source-Pharma Trac (May’2014)
| Unique No. as per NLEM | Name of the Product | Composition of the Product | Company | Brands | Dosage Form | Pack Size (In ml) | Price to Retailer | MAT Value as on May’14 | MAT % | Price per ml |
|---|---|---|---|---|---|---|---|---|---|---|
| 21.4.4 | Brimonidine Tartrate 2 MG and Timolol Maleate 5 mg Eye Drops | Each ml contains: Brimonidine tartrate 2mg Timolol maleate eq. to timolol 5mg Benzalkonium Chloride 0.005% w/v |
Alembic Ltd. | Albrim Lst | Eye Drops | 5 | 153.99 | ###### | 100.00% | 30.80 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
###### | 100.00% | 30.80 |
-- |
Monopoly situation as only M/s. Alembic Ltd. is the known manufacturer | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
PTR per unit | -- |
-- |
30.80 | -- |
-- |
-- |
-- |
-- |
-- |
-- |
Price fixed in the relevant sub-section for other similar drugs is as follows | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Section: 21.4: Miotics and Antiglucoma medicines | -- |
-- |
-- |
-- |
|||||
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | Unit Ceiling Price (Rs.) | Meeting No. | S.O. No. | Date | % Reduction w.r.t. Highest Price | -- |
| 1 | Timolol Maleate | P,S,T | Drops | 0.25% | 4.46 | 5th | 2252(E) | 22.07.2013 | 24.28% | -- |
| 2 | Timolol Maleate | P,S,T | Drops | 0.50% | 12.07 | 5th | 2253(E) | 22.07.2013 | 54.36% | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Average Reduction | 39.32% | -- |
|
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Therefore, PTR per unit | 30.80x(1-39.32%) | 18.69 | -- |
-- |
-- |
-- |
-- |
||
-- |
Add: 16% Retailer Margin | -- |
2.99 | -- |
-- |
-- |
-- |
-- |
||
-- |
Retail Price per unit | -- |
21.68 | -- |
-- |
-- |
-- |
-- |
||
-- |
Retail Price for 5 ml Vial | -- |
108.40 | -- |
S.O. No. | -- |
-- |
-- |
||
Source of Data-IMS (Jan, 2014)
| S.No. | Composition of the Product | Pack Description | Compan | Dosage Form | Pack size | Price to Retailer (Rs.) | MAT Value | MAT % | Price per ml |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Ranitidine Oral Solution Each 5 ml contains: Ranitidine HCL eq. to Ranitidine 75 mg |
Rantac Syrup 75 mg 100 ML x 1 (/5ml) | Unique Phar | Syrup | 100 | 52.95 | ####### | ##### | 0.53 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
###### | ##### | 0.53 |
-- |
-- |
-- |
-- |
-- |
|||||
-- |
Monopoly situation as only M/s. Unique Pharm. is the known manufacturer | -- |
-- |
-- |
-- |
-- |
|||
-- |
PTR per unit | -- |
-- |
0.53 | -- |
-- |
-- |
-- |
|
-- |
Price fixed in the relevant sub-section for other similar drugs is as follows: | -- |
-- |
-- |
-- |
-- |
|||
-- |
Section 17- Gastrointestinal medicines | -- |
-- |
-- |
|||||
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | Unit Ceiling Price (Rs.) | Meeting No. | S.O. No. | Date | % Reduction w.r.t. Highest Price |
| 1 | Ranitidine | P,S, T | Injection | 25 mg/ml | 1.43 | 14th | 1157 | 28.04.2014 | 15.17% |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Average Reduction | 15.17% | |
-- |
-- |
-- |
-- |
-- |
|||||
-- |
Therefore, PTR per unit | 0.53x(1-15.17%) | 0.45 | -- |
-- |
-- |
|||
-- |
Add: 16% Retailer Margin | -- |
0.07 | -- |
-- |
-- |
|||
-- |
Retail Price per unit | -- |
0.52 | -- |
S.O. No. 850(E) dt. 25.03.2015 | ||||
Source of Data-Pharma Trac/Company
| Unique No. as per NLEM | Name of the Product | Composition of the product | Compan | Brands | Dosage Form | Pack size | Price to Retailer (Rs.) | MAT Value as on May’2013 | MAT % | Price per unit |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.3.2.4 | Suppam-2.5 | Diazepam-2.5 mg | Bliss GVS P | SLIPIZE M-2.5 | Suppositories | 5 | 32.51 | 16,590 | 100% | 6.50 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
##### | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|||||
-- |
Monopoly situation as only M/s. Bliss Pharma is the known manufacturer | -- |
-- |
-- |
-- |
-- |
-- |
-- |
||
-- |
PTR per unit | -- |
-- |
6.50 | -- |
-- |
-- |
-- |
-- |
|
-- |
Price fixed in the relevant sub-section for other similar drugs is as follows: | -- |
-- |
-- |
-- |
-- |
-- |
|||
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|||
-- |
Section :- 1.3 | -- |
-- |
-- |
-- |
-- |
||||
-- |
1.3 Preoperative Medication and Sedation for Short Term Procedures | -- |
-- |
-- |
-- |
|||||
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | Unit Ceiling Price (Rs.) | Meeting No. | S.O. No. | Date | % Reduction w.r.t. Highest Price | -- |
| 1 | Diazepam | S, T | Suppository | 5 mg | 5.15 | 19th | 3128(E) | 10.12.2014 | 48.38% | -- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Average Reduction | 48.38% | -- |
|
-- |
-- |
-- |
-- |
-- |
-- |
|||||
-- |
Therefore, PTR per unit | 6.50x(1-48.38%) | 3.36 | -- |
-- |
-- |
-- |
|||
-- |
Add: 16% Retailer Margin | -- |
0.54 | -- |
-- |
-- |
-- |
|||
-- |
Retail Price per unit | -- |
3.90 | S.O. No. 852(E) dt. 25.03.2015 | -- |
-- |
||||
Source of Data – Pharma Trac/Companies (April, 2014)
| S.No. | Composition of the Product | Company | Dosage Form | Pack size | Price to Retailer (Rs.) | MAT Value | MAT % | Price per tablet | Retail Price with 16 % Margin |
|---|---|---|---|---|---|---|---|---|---|
-- |
Accef O Each film coated tablet contains: Cefixime IP as Trihydrate eq. to Anhydrous Cefixime 200 mg Ofloxacin IP 200 mg |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
| 1 | ZIMNIC O 200/200 MG TABLET 6 | ABBOTT HEALTHCARE PVT. LTD | Tablet | 6 | 91.96 | 82724401.13 | 3.87% | 15.33 | -- |
| 2 | CEFI O 200/200 MG TABLET 10 | ABBOTT HEALTHCARE PVT. LTD | Tablet | 10 | 91.96 | 82123130.76 | 3.84% | 9.20 | -- |
| 3 | TYSURE 200/200 MG TABLET 10 | ABBOTT HEALTHCARE PVT. LTD | Tablet | 10 | 101.25 | 8378411.97 | 0.39% | 10.13 | -- |
| 4 | ASERT PLUS 200/200 MG TABLET 10 | ABBOTT HEALTHCARE PVT. LTD | Tablet | 10 | 100.34 | 5713989.16 | 0.27% | 10.03 | -- |
| 5 | PUOCEF 200/200 MG TABLET 10 | AKUMENTIS HEALTHCARE LTD | Tablet | 10 | 90.67 | 8129472.20 | 0.38% | 9.07 | -- |
| 6 | ZOFIX O 200/200 MG TABLET 10 | ALEMBIC LTD | Tablet | 10 | 88.38 | 35567028.54 | 1.66% | 8.84 | -- |
| 7 | TAXIM OF 200/200 MG TABLET 10 | ALKEM LABORATORIES LTD. | Tablet | 10 | 160.92 | 87974320.32 | 4.12% | 16.09 | -- |
| 8 | PEXOFLOX 200/200 MG TABLET 10 | APEX LABORATORIES LTD. | Tablet | 10 | 75.50 | 5620899.50 | 0.26% | 7.55 | -- |
| 9 | AREXCEF O 200/200 MG TABLET 10 | AR-EX LABORATORIES PVT . LTD | Tablet | 10 | 91.43 | 250975.35 | 0.01% | 9.14 | -- |
| 10 | OMCEF 200/200 MG TABLET 10 | ARISTO PHARMACEUTICALS PVT.LTD | Tablet | 10 | 67.17 | 85941500.55 | 4.02% | 6.72 | -- |
| 11 | ABCEF O 200/200 MG TABLET 10 | BESTOCHEM FORMULATIONS (I) LTD | Tablet | 10 | 82.29 | 7684850.88 | 0.36% | 8.23 | -- |
| 12 | BIOTAX OF 200/200 MG TABLET 10 | BIOCHEM PHARMACEUTICAL INDS | Tablet | 10 | 75.43 | 9473178.27 | 0.44% | 7.54 | -- |
| 13 | EXTACEF PLUS 200/200 MG TABLET 10 | BLUE CROSS LABORATORIES LTD | Tablet | 10 | 75.43 | 32534467.60 | 1.52% | 7.54 | -- |
| 14 | TRAXOF 200/200 MG TABLET 10 | CACHET PHARMACEUTICALS PVT LTD | Tablet | 10 | 80.00 | 10304560.00 | 0.48% | 8.00 | -- |
| 15 | CEFOCEF PLUS 200/200 MG TABLET 10 | CENTAUR PHARMACEUTICALS PVT.LTD | Tablet | 10 | 98.03 | 4582667.64 | 0.21% | 9.80 | -- |
| 16 | OMNIX O 200/200 MG TABLET 10 | CIPLA LTD. | Tablet | 10 | 91.43 | 53121744.30 | 2.49% | 9.14 | -- |
| 17 | XECUTE O 200/200 MG TABLET 10 | CORONA | Tablet | 10 | 90.66 | 15868310.46 | 0.74% | 9.07 | -- |
| 18 | DELPOCEFT 200/200 MG TABLET 10 | DELCURE LIFE SCIENCES | Tablet | 10 | 90.67 | 1377639.98 | 0.06% | 9.07 | -- |
| 19 | JIFON O 200/200 MG TABLET 10 | DR. JOHNS LABORATORIES PVT LTD | Tablet | 10 | 83.81 | 3369832.48 | 0.16% | 8.38 | -- |
| 20 | FORMIC OF 200/200 MG TABLET 10 | ELDER PHARMACEUTICALS LTD | Tablet | 10 | 82.29 | 22459821.15 | 1.05% | 8.23 | -- |
| 21 | ELFI O 200/200 MG TABLET 10 | ELDER PHARMACEUTICALS LTD | Tablet | 10 | 82.29 | 5294127.15 | 0.25% | 8.23 | -- |
| 22 | C-LET OF 200/200 MG TABLET 10 | EMCURE PHARMACEUTICALS LTD | Tablet | 10 | 152.38 | 290588.66 | 0.01% | 15.24 | -- |
| 23 | ZIFI O 200/200 MG TABLET 10 | FDC LTD. | Tablet | 10 | 90.66 | 135076328.52 | 6.32% | 9.07 | -- |
| 24 | CO FORCE 200/200 MG TABLET 10 | FDC LTD. | Tablet | 10 | 90.66 | 15408754.78 | 0.72% | 9.07 | -- |
| 25 | MILIXIM O 200/200 MG TABLET 10 | GLENMARK PHARMACEUTICALS LTD. | Tablet | 10 | 66.66 | 97420677.50 | 4.56% | 6.67 | -- |
| 26 | CEFIGLEN O 200/200 MG TABLET 1 | GLENMARK PHARMACEUTICALS LTD. | Tablet | 10 | 64.40 | 836427.20 | 0.04% | 6.44 | -- |
| 27 | ALMOCEF O 200/200 MG TABLET 10 | GUJARAT TERCE LABORATORIES LTD | Tablet | 10 | 118.10 | 1662611.80 | 0.08% | 11.81 | -- |
| 28 | HIFEN PLUS 200/200 MG TABLET 10 | HETERO HEALTHCARE LTD | Tablet | 10 | 75.43 | 74098434.21 | 3.47% | 7.54 | -- |
| 29 | OFFICE 200/200 MG TABLET 10 | HETERO HEALTHCARE LTD | Tablet | 10 | 75.43 | 32691362.00 | 1.53% | 7.54 | -- |
| 30 | OFAL C2 200/200 MG TABLET 10 | HI TEC PHARMACEUTICALS PVT LTD | Tablet | 10 | 90.67 | 1132830.98 | 0.05% | 9.07 | -- |
| 31 | IATROCEF O 200/200 MG TABLET 10 | IATROS PHARMACEUTICALS PVT. LTD. | Tablet | 10 | 83.81 | 1067739.40 | 0.05% | 8.38 | -- |
| 32 | ECOCEF O 200/200 MG TABLET 10 | INDCHEMIE HEALTH SPECIALITIES PVT. LTD. | Tablet | 10 | 109.71 | 8482713.94 | 0.40% | 10.97 | -- |
| 33 | INXIM-O 200/200 MG TABLET 10 | INDI PHARMA | Tablet | 10 | 76.19 | 2737887.65 | 0.13% | 7.62 | -- |
| 34 | FEVORIT O 200/200 MG TABLET 10 | INDOCO REMEDIES LTD | Tablet | 10 | 84.69 | 11697458.85 | 0.55% | 8.47 | -- |
| 35 | VCEF PLUS 200/200 MG TABLET 10 | INDOCO REMEDIES LTD | Tablet | 10 | 83.85 | 5839230.81 | 0.27% | 8.39 | -- |
| 36 | CEFTAS O 200/200 MG TABLET 10 | INTAS PHARMACEUTICALS LTD | Tablet | 10 | 66.74 | 42588796.20 | 1.99% | 6.67 | -- |
| 37 | OLFICEF 200/200 MG TABLET 10 | IPCA LABORATORIES PVT LTD. | Tablet | 10 | 91.35 | 10096458.75 | 0.47% | 9.14 | -- |
| 38 | OFCEF 200/200 MG TABLET 10 | JB CHEMICALS | Tablet | 10 | 71.24 | 29328311.20 | 1.37% | 7.12 | -- |
| 39 | OQ-CEF 200/200 MG TABLET 10 | JB CHEMICALS | Tablet | 10 | 64.76 | 4412681.64 | 0.21% | 6.48 | -- |
| 40 | OJEN PLUS 200/200 MG TABLET 10 | JENBURKT PHARMACEUTICALS LTD | Tablet | 10 | 65.52 | 18721039.42 | 0.88% | 6.55 | -- |
| 41 | KINECEF O 200/200 MG TABLET 10 | KINEDEX HEALTH CARE PVT LTD | Tablet | 10 | 105.90 | 537760.20 | 0.03% | 10.59 | -- |
| 42 | TRIXON PLUS 200/200 MG TABLET 10 | LINCOLN PHARMACEUTICALS LTD | Tablet | 10 | 86.78 | 6279834.70 | 0.29% | 8.68 | -- |
| 43 | LUFIXCIN 200/200 MG TABLET 10 | LUPIN LTD | Tablet | 10 | 68.50 | 23230062.50 | 1.09% | 6.85 | -- |
| 44 | CEFOLAC O 200/200 MG TABLET 10 | MACLEODS PHARMACEUTICALS PVT.LTD | Tablet | 10 | 76.11 | 93753820.20 | 4.39% | 7.61 | -- |
| 45 | OFLOMAC CX 200/200 MG TABLET 10 | MACLEODS PHARMACEUTICALS PVT.LTD | Tablet | 10 | 76.11 | 24441356.52 | 1.14% | 7.61 | -- |
| 46 | SI-FIXIM O 200/200 MG TABLET 10 | MANEESH PHARMACEUTICALS LTD | Tablet | 10 | 100.78 | 8341678.84 | 0.39% | 10.08 | -- |
| 47 | MAHACEF PLUS 200/200 MG TABLET 10 | MANKIND PHARMACEUTICALS LTD. | Tablet | 10 | 75.43 | 293896225.35 | 13.75% | 7.54 | -- |
| 48 | ZENFLOX PLUS 200/200 MG TABLET 10 | MANKIND PHARMACEUTICALS LTD. | Tablet | 10 | 75.43 | 179868256.01 | 8.42% | 7.54 | -- |
| 49 | BRUTACEF O 200/200 MG TABLET 10 | MANKIND PHARMACEUTICALS LTD. | Tablet | 10 | 75.43 | 21275739.78 | 1.00% | 7.54 | -- |
| 50 | FIXIMEC O 200/200 MG TABLET 10 | McW HEALTHCARE (P) LTD. | Tablet | 10 | 83.81 | 2934188.00 | 0.14% | 8.38 | -- |
| 51 | KEFCEF O 200/200 MG TABLET 10 | MED MANOR ORGANICS PVT LTD. | Tablet | 10 | 67.81 | 5248311.60 | 0.25% | 6.78 | -- |
| 52 | CO2 200/200 MG TABLET 10 | MEDLEY PHARMACEUTICALS | Tablet | 10 | 76.23 | 60605670.51 | 2.84% | 7.62 | -- |
| 53 | CEFO PLUS (MEDLEY) 200/200 MG TABLET 10 | MEDLEY PHARMACEUTICALS | Tablet | 10 | 75.43 | 9940980.35 | 0.47% | 7.54 | -- |
| 54 | GRAMOCEF OF 200/200 MG TABLET 10 | MICRO LABS LTD | Tablet | 10 | 90.66 | 28297433.82 | 1.32% | 9.07 | -- |
| 55 | SECEF O 200/200 MG TABLET 10 | NOVARTIS INDIA LTD | Tablet | 10 | 90.67 | 6759687.00 | 0.32% | 9.07 | -- |
| 56 | OBEFEX O 200/200 MG TABLET 10 | OBSURGE PHARMA (P) LTD | Tablet | 10 | 98.67 | 5132813.40 | 0.24% | 9.87 | -- |
| 57 | ORFIX O 200/200 MG TABLET 10 | ORCHID CHEMICALS & PHARMACEUTICALS L | Tablet | 10 | 72.38 | 5052775.42 | 0.24% | 7.24 | -- |
| 58 | VALUECEF-O 200/200 MG TABLET 10 | PANACEA BIOTEC LTD | Tablet | 10 | 83.70 | 3448356.30 | 0.16% | 8.37 | -- |
| 59 | ZIFEXIM 200/200 MG TABLET 10 | RANBAXY LABORATORIES LTD | Tablet | 10 | 90.67 | 95969026.81 | 4.49% | 9.07 | -- |
| 60 | TOPCEF O 200/200 MG TABLET 10 | TORRENT PHARMACEUTICALS LTD. | Tablet | 10 | 83.81 | 24550211.87 | 1.15% | 8.38 | -- |
| 61 | CEFIPOWER 200/200 MG TABLET 10 | UNICHEM LABORATORIES LTD | Tablet | 10 | 76.80 | 59335680.00 | 2.78% | 7.68 | -- |
| 62 | DELBI O 200/200 MG TABLET 10 | VERITAZ HEALTHCARE LTD | Tablet | 10 | 85.46 | 18939132.44 | 0.89% | 8.55 | -- |
| 63 | VILCOCEF-O 200/200 MG TABLET 10 | VILCO LABORATORIES LTD | Tablet | 10 | 96.84 | 4268900.88 | 0.20% | 9.68 | -- |
| 64 | TRICEF O 200/200 MG TABLET 10 | WOCKHARDT LTD | Tablet | 10 | 91.39 | 30420349.57 | 1.42% | 9.14 | -- |
| 65 | CEFIWOK O 200/200 MG TABLET 10 | WOCKHARDT LTD | Tablet | 10 | 99.96 | 21450868.42 | 1.00% | 10.00 | -- |
| 66 | OZEEFIX 200/200 MG TABLET 10×10 | ZEST PHAMRA | Tablet | 100 | 816.00 | 423016.00 | 0.02% | 8.16 | -- |
| 67 | C TAX OF 200/200 MG TABLET 10 | ZUVENTUS HEALTHCARE LTD | Tablet | 10 | 112.76 | 8907927.24 | 0.42% | 11.28 | -- |
| 68 | CLAVICEF O 200/200 MG TABLET 10 | ZYDUS CADILA | Tablet | 10 | 82.67 | 31263017.29 | 1.46% | 8.27 | -- |
-- |
-- |
-- |
-- |
-- |
-- |
2,136,658,744 | 100.00% | 8.50 | 9.86 |
-- |
-- |
-- |
-- |
-- |
-- |
Maximum | 16.09 | Minimum | 6.44 |
-- |
-- |
-- |
-- |
-- |
|||||
-- |
As per the above there are 22 companies consisting of Market Share of 1% & Above | -- |
|||||||
-- |
Sum of MAT value considered for price calculation | -- |
-- |
19319.93 | (Rs. in Lakhs) | -- |
|||
-- |
Sum of PTR per unit considered for price calculation | -- |
-- |
297.54 | -- |
-- |
|||
-- |
Number of Packs considered | -- |
-- |
35 | -- |
-- |
-- |
||
-- |
Retail Price | -- |
-- |
8.50 | -- |
-- |
|||
-- |
Add : 16% Retailer Margin | -- |
-- |
1.36 | -- |
-- |
|||
-- |
MRP (without local taxes) | -- |
-- |
9.86 | S.O. No. 848(E) dt. 25.03.2015 | -- |
|||
-- |
% Reduction with compared to Highest Price | -- |
-- |
47.17% | -- |
-- |
|||
Source of Data-Company (Dec’ 2013)
| S.No. | Composition of the Product | Brand Name | Company | Dosage Form | Pack size(In ml) | Price to Retailer (Rs.) | MAT Value | MAT % | Price per unit |
|---|---|---|---|---|---|---|---|---|---|
-- |
Cyclosporine Eye Drops 0.1% w/v IFLO Each ml contains: Cyclosporine USP 1mg Benzalkonium Chloride 0.01% w/v (as preservative) |
Cyclomune | Sun Pharma Laboratories Ltd. | Drop | 3 | 266.67 | 1.8E+07 | 100% | 88.89 |
-- |
-- |
-- |
-- |
-- |
-- |
Average | 88.89 | ||
-- |
Monopoly situation as only M/s. Sun Pharma is the known manufacturer | -- |
-- |
-- |
-- |
-- |
|||
-- |
PTR per unit | -- |
-- |
88.89 | -- |
-- |
-- |
-- |
-- |
-- |
Price fixed in the relevant sub-section for other similar drugs is as follows: | -- |
-- |
-- |
-- |
-- |
|||
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|||
-- |
Section: 8 – Antineoplastic, immunosuppressives and medicines used in palliative care | -- |
-- |
-- |
-- |
||||
-- |
8.1: Immunosuppressive medicines | -- |
-- |
-- |
-- |
-- |
|||
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | Unit Ceiling Price (Rs.) | Meeting No. | S.O. No. | Date | % Reduction w.r.t. Highest Price |
-- |
Cyclosporine | T | Capsules | 10 mg | -- |
No data | -- |
||
-- |
Cyclosporine | T | Capsules | 25 mg | 26.31 | 1st | 1602 | 14.06.2013 | 27.91% |
-- |
Cyclosporine | T | Capsules | 50 mg | 51.31 | 1st | 1603 | 14.06.2013 | 29.63% |
-- |
Cyclosporine | T | Capsules | 100 mg | 113.01 | 3rd | 1889 | 28.06.2013 | 37.77% |
-- |
Cyclosporine | T | Concentrate for Injection | 100 mg/ml | 126.14 | 8th | 3333 | 05.11.2013 | 29.42% |
-- |
-- |
-- |
Average Reduction | 31.18% | |||||
-- |
Therefore, PTR per unit | -- |
88.89x(1-31.18%) | -- |
61.17 | -- |
-- |
-- |
|
-- |
Add: 16% Retailer Margin | -- |
-- |
9.79 | -- |
-- |
-- |
||
-- |
Retail Price per ml | -- |
-- |
70.96 | -- |
-- |
-- |
||
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
||
-- |
Retail Price per 3 ml | -- |
-- |
-- |
212.88 | S.O. No. 850(E) dt. 25.03.2015 | -- |
||
Source of Data-Company (Jan’ 2014)
| S.No. | Composition of the Product | Brand Name | Company | Dosage Form | Pack size | Price to Retailer (Rs.) | MAT Value | MAT % | Price per unit |
|---|---|---|---|---|---|---|---|---|---|
| 1 | FEROMEGA XT Each film coated tablet contains: Adenosylcobalamin 15 mcg Ferrous Ascorbate eq. to Elemental iron 100 mg Zinc Sulphate Monohydrate eq. to Elemtal Zinc 22.5 mg Folic Acid 1.5 mg |
-- |
Albert David Limited | Tablet | 10 | 58.21 | ####### | 100% | 5.82 |
-- |
-- |
-- |
-- |
-- |
-- |
Average | 5.82 | ||
-- |
Monopoly situation as only M/s. Albert David Limited is the known manufacturer | -- |
-- |
-- |
-- |
-- |
|||
-- |
PTR per unit | -- |
-- |
5.82 | -- |
-- |
-- |
-- |
-- |
-- |
Price fixed in the relevant sub-section for other similar drugs is as follows: | -- |
-- |
-- |
-- |
-- |
|||
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|||
-- |
10.1: Antianaemia medicines | -- |
-- |
-- |
-- |
-- |
|||
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | Unit Ceiling Price (Rs.) | Meeting No. | S.O. No. | Date | % Reduction w.r.t. Highest Price |
-- |
Folic Acid | P,S,T | Tablets | 1 mg | 0.25 | 8th | 3365(E) | 05.11.2013 | 48.07% |
-- |
Folic Acid | P,S,T | Tablets | 5 mg | 1.37 | 9th | 3570(E) | 02.12.2013 | 38.02% |
-- |
17.6.2 Antidiarrhoeal medicines | -- |
-- |
-- |
-- |
-- |
-- |
||
-- |
Zinc Sulfate | P,S,T | Syrup | 20 mg/5ml | 0.61 | 19th | 3126(E) | 10.12.2014 | 45.56% |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
Average Reduction | 43.88% | |||||
-- |
-- |
-- |
-- |
-- |
|||||
-- |
Therefore, PTR per unit | -- |
5.82x(1-43.88%) | -- |
3.27 | -- |
-- |
-- |
|
-- |
Add: 16% Retailer Margin | -- |
-- |
0.52 | -- |
-- |
-- |
||
-- |
Retail Price per tablet | -- |
-- |
3.79 | S.O. No. 853(E) dt. 25.03.2015 | -- |
|||
Source of Data-Pharma Trac (April’ 2014)
| S.No. | Composition of the Product | Brand Name | Company | Dosage Form | Pack size | Price to Retailer (Rs.) | MAT Value | MAT % | Price per unit |
|---|---|---|---|---|---|---|---|---|---|
| 1 | AMLONG-VL 80 tablet Each film coated tablet contains: Amlodipine Besilate eq.to Amlodipine 5 mg Valsartan 80 mg |
Amlopres VL | Cipla Ltd. | Tablet | 10 | 50.04 | ####### | 100% | 5.00 |
-- |
-- |
-- |
-- |
-- |
-- |
Average | 5.00 | ||
-- |
Monopoly situation as only M/s. Cipla Ltd. is the known manufacturer | -- |
-- |
-- |
-- |
-- |
|||
-- |
PTR per unit | -- |
-- |
5.00 | -- |
-- |
-- |
-- |
-- |
-- |
Price fixed in the relevant sub-section for other similar drugs is as follows: | -- |
-- |
-- |
-- |
-- |
|||
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|||
-- |
12.3: Antihypertensive medicines | -- |
-- |
-- |
-- |
-- |
|||
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | Unit Ceiling Price (Rs.) | Meeting No. | S.O. No. | Date | % Reduction w.r.t. Highest Price |
-- |
Amlodipine | P,S,T | Tablets | 5 mg | 2.83 | 10th | 3773(E) | 20.12.2013 | 62.23% |
-- |
-- |
-- |
Average Reduction | 62.23% | |||||
-- |
-- |
-- |
-- |
-- |
|||||
-- |
Therefore, PTR per unit | -- |
5.00x(1-62.23%) | -- |
1.89 | -- |
-- |
-- |
|
-- |
Add: 16% Retailer Margin | -- |
-- |
0.30 | -- |
-- |
-- |
||
-- |
Retail Price per tablet | -- |
-- |
2.19 | S.O. No. 854(E) dt. 25.03.2015 | -- |
|||
Source of Data-Pharma Trac (April’ 2014)
| S.No. | Composition of the Product | Brand Name | Company | Dosage Form | Pack size | Price to Retailer (Rs.) | MAT Value | MAT % | Price per unit |
|---|---|---|---|---|---|---|---|---|---|
| 1 | AMLONG-VL 160 tablet Each film coated tablet contains: Amlodipine Besilate eq.to Amlodipine 5 mg Valsartan 160 mg |
AMLOPRES VL | Cipla Ltd. | Tablet | 10 | 77 | ####### | 100% | 7.70 |
-- |
-- |
-- |
-- |
-- |
-- |
Average | 7.70 | ||
-- |
Monopoly situation as only M/s. Cipla Ltd. is the known manufacturer | -- |
-- |
-- |
-- |
-- |
|||
-- |
PTR per unit | -- |
-- |
7.70 | -- |
-- |
-- |
-- |
-- |
-- |
Price fixed in the relevant sub-section for other similar drugs is as follows: | -- |
-- |
-- |
-- |
-- |
|||
-- |
12.3: Antihypertensive medicines | -- |
-- |
-- |
-- |
-- |
|||
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | Unit Ceiling Price (Rs.) | Meeting No. | S.O. No. | Date | % Reduction w.r.t. Highest Price |
-- |
Amlodipine | P,S,T | Tablets | 5 mg | 2.83 | 10th | 3773(E) | 20.12.2013 | 62.23% |
-- |
-- |
-- |
Average Reduction | 62.23% | |||||
-- |
Therefore, PTR per unit | -- |
7.70x(1-62.23%) | -- |
2.91 | -- |
-- |
-- |
|
-- |
Add: 16% Retailer Margin | -- |
-- |
0.47 | -- |
-- |
-- |
||
-- |
Retail Price per tablet | -- |
-- |
3.38 | S.O. No. 854(E) dt. 25.03.2015 | -- |
|||
Source of Data-Pharma Trac (April’ 2014)
| S.No. | Composition of the Product | Brand Name | Company | Dosage Form | Pack size | Price to Retailer (Rs.) | MAT Value | MAT % | Price per unit |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CTD-AM 12.5/5 Each uncoated tablet contains: Chlorthalidone 12.5 mg Amlodipine Besilate eq.to Amlodipine 5 mg |
AMLODAC CH | Zydus Cadila | Tablet | 10 | 53.13 | ####### | 100% | 5.31 |
-- |
-- |
-- |
-- |
-- |
-- |
Average | 5.31 | ||
-- |
Monopoly situation as only M/s. Zydus Cadila is the known manufacturer | -- |
-- |
-- |
-- |
-- |
|||
-- |
PTR per unit | -- |
-- |
5.31 | -- |
-- |
-- |
-- |
-- |
-- |
Price fixed in the relevant sub-section for other similar drugs is as follows: | -- |
-- |
-- |
-- |
-- |
|||
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|||
-- |
12.3: Antihypertensive medicines | -- |
-- |
-- |
-- |
-- |
|||
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | Unit Ceiling Price (Rs.) | Meeting No. | S.O. No. | Date | % Reduction w.r.t. Highest Price |
-- |
Amlodipine | P,S,T | Tablets | 5 mg | 2.83 | 10th | 3773(E) | 20.12.2013 | 62.23% |
-- |
-- |
-- |
Average Reduction | 62.23% | |||||
-- |
Therefore, PTR per unit | -- |
5.31x(1-62.23%) | -- |
2.01 | -- |
-- |
-- |
|
-- |
Add: 16% Retailer Margin | -- |
-- |
0.32 | -- |
-- |
-- |
||
-- |
Retail Price per tablet | -- |
-- |
2.33 | S.O. No. 855(E) dt. 25.03.2015 | -- |
|||
Last Page Updated: 10-01-2019
Copyright © 2023 - All Rights Reserved- Official Website of National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Government of India
Note :Website Content Managed by National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Designed, Developed and Hosted by National Informatics Centre Services Inc.(NICSI)